These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
75-3108137
|
|
State of Incorporation
|
IRS Employer Identification No.
|
|
11825 N. Pennsylvania Street
|
||
Carmel, Indiana 46032
|
(317) 817-6100
|
|
Address of principal executive offices
|
Telephone
|
PART I - FINANCIAL INFORMATION
|
Page
|
|
Financial Statements
|
||
Consolidated Balance Sheet as of June 30, 2010 and December 31, 2009
|
3
|
|
Consolidated Statement of Operations for the three and six months ended June 30, 2010
and 2009
|
5
|
|
Consolidated Statement of Shareholders’ Equity for the six months ended June 30, 2010 and 2009
|
6
|
|
Consolidated Statement of Cash Flows for the six months ended June 30, 2010 and 2009
|
7
|
|
Notes to Consolidated Financial Statements
|
8
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
51
|
Cautionary Statement Regarding Forward-Looking Statements
|
51
|
|
Overview
|
53
|
|
Critical Accounting Policies
|
55
|
|
Results of Operations
|
55
|
|
Premium Collections
|
71
|
|
Liquidity and Capital Resources
|
75
|
|
Investments
|
85
|
|
Investment in Variable Interest Entities
|
93
|
|
New Accounting Standards
|
95
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
95
|
Item 4.
|
Controls and Procedures
|
95
|
PART II - OTHER INFORMATION
|
||
Item 1.
|
Legal Proceedings
|
96
|
Item 1A.
|
Risk Factors
|
96
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
96
|
Item 5.
|
Other Information
|
97
|
Item 6.
|
Exhibits
|
97
|
June 30,
|
December 31,
|
|||||||
2010
|
2009
|
|||||||
(unaudited)
|
||||||||
Investments:
|
||||||||
Actively managed fixed maturities at fair value (amortized cost: June 30, 2010 - $19,280.3; December 31, 2009 - $18,998.0)
|
$ | 19,935.7 | $ | 18,528.4 | ||||
Equity securities at fair value (cost: June 30, 2010 - $30.7; December 31, 2009 - $30.7)
|
31.0 | 31.0 | ||||||
Mortgage loans
|
1,948.1 | 1,965.5 | ||||||
Policy loans
|
292.9 | 295.2 | ||||||
Trading securities
|
360.7 | 293.3 | ||||||
Investments held by variable interest entities
|
478.4 | - | ||||||
Securities lending collateral
|
77.6 | 180.0 | ||||||
Other invested assets
|
167.2 | 236.8 | ||||||
Total investments
|
23,291.6 | 21,530.2 | ||||||
Cash and cash equivalents - unrestricted
|
323.7 | 523.4 | ||||||
Cash and cash equivalents held by variable interest entities
|
13.5 | 3.4 | ||||||
Accrued investment income
|
323.1 | 309.0 | ||||||
Value of policies inforce at the Effective Date
|
1,077.3 | 1,175.9 | ||||||
Cost of policies produced
|
1,700.0 | 1,790.9 | ||||||
Reinsurance receivables
|
3,357.2 | 3,559.0 | ||||||
Income tax assets, net
|
769.0 | 1,124.0 | ||||||
Assets held in separate accounts
|
15.6 | 17.3 | ||||||
Other assets
|
349.8 | 310.7 | ||||||
Total assets
|
$ | 31,220.8 | $ | 30,343.8 |
June 30,
|
December 31,
|
|||||||
2010
|
2009
|
|||||||
(unaudited)
|
||||||||
Liabilities:
|
||||||||
Liabilities for insurance products:
|
||||||||
Interest-sensitive products
|
$ | 13,177.8 | $ | 13,219.2 | ||||
Traditional products
|
10,199.7 | 10,063.5 | ||||||
Claims payable and other policyholder funds
|
946.0 | 994.0 | ||||||
Liabilities related to separate accounts
|
15.6 | 17.3 | ||||||
Other liabilities
|
683.6 | 610.4 | ||||||
Investment borrowings
|
454.2 | 683.9 | ||||||
Borrowings related to variable interest entities
|
449.7 | - | ||||||
Securities lending payable
|
82.0 | 185.7 | ||||||
Notes payable – direct corporate obligations
|
1,029.4 | 1,037.4 | ||||||
Total liabilities
|
27,038.0 | 26,811.4 | ||||||
Commitments and Contingencies
|
||||||||
Shareholders' equity:
|
||||||||
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding:
June 30, 2010 – 251,044,745; December 31, 2009 – 250,786,216)
|
2.5 | 2.5 | ||||||
Additional paid-in capital
|
4,418.8 | 4,408.8 | ||||||
Accumulated other comprehensive income (loss)
|
318.8 | (264.3 | ) | |||||
Accumulated deficit
|
(557.3 | ) | (614.6 | ) | ||||
Total shareholders' equity
|
4,182.8 | 3,532.4 | ||||||
Total liabilities and shareholders' equity
|
$ | 31,220.8 | $ | 30,343.8 |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Revenues:
|
||||||||||||||||
Insurance policy income
|
$ | 667.9 | $ | 791.3 | $ | 1,332.5 | $ | 1,574.1 | ||||||||
Net investment income (loss):
|
||||||||||||||||
General account assets
|
321.1 | 308.5 | 636.3 | 617.3 | ||||||||||||
Policyholder and reinsurer accounts and other special- purpose portfolios
|
(22.7 | ) | 9.0 | 1.3 | (9.2 | ) | ||||||||||
Realized investment gains (losses):
|
||||||||||||||||
Net realized investment gains, excluding impairment losses
|
11.2 | 20.3 | 26.6 | 105.4 | ||||||||||||
Other-than-temporary impairment losses:
|
||||||||||||||||
Total other-than-temporary impairment losses
|
(29.3 | ) | (53.7 | ) | (47.0 | ) | (161.8 | ) | ||||||||
Change in other-than-temporary impairment losses recognized in accumulated other comprehensive income (loss)
|
1.4 | 17.1 | (1.2 | ) | 33.2 | |||||||||||
Net impairment losses recognized
|
(27.9 | ) | (36.6 | ) | (48.2 | ) | (128.6 | ) | ||||||||
Total realized gains (losses)
|
(16.7 | ) | (16.3 | ) | (21.6 | ) | (23.2 | ) | ||||||||
Fee revenue and other income
|
3.6 | 3.1 | 7.1 | 6.1 | ||||||||||||
Total revenues
|
953.2 | 1,095.6 | 1,955.6 | 2,165.1 | ||||||||||||
Benefits and expenses:
|
||||||||||||||||
Insurance policy benefits
|
651.0 | 781.1 | 1,350.0 | 1,534.6 | ||||||||||||
Interest expense
|
28.7 | 32.7 | 56.2 | 55.9 | ||||||||||||
Amortization
|
96.6 | 101.8 | 199.2 | 222.6 | ||||||||||||
Loss on extinguishment or modification of debt
|
.9 | - | 2.7 | 9.5 | ||||||||||||
Other operating costs and expenses
|
124.2 | 130.4 | 242.6 | 250.7 | ||||||||||||
Total benefits and expenses
|
901.4 | 1,046.0 | 1,850.7 | 2,073.3 | ||||||||||||
Income before income taxes
|
51.8 | 49.6 | 104.9 | 91.8 | ||||||||||||
Income tax expense:
|
||||||||||||||||
Tax expense on period income
|
18.7 | 17.4 | 37.9 | 32.7 | ||||||||||||
Valuation allowance for deferred tax assets
|
- | 4.6 | - | 7.0 | ||||||||||||
Net income
|
$ | 33.1 | $ | 27.6 | $ | 67.0 | $ | 52.1 | ||||||||
Earnings per common share:
|
||||||||||||||||
Basic:
|
||||||||||||||||
Weighted average shares outstanding
|
250,994,000 | 184,820,000 | 250,891,000 | 184,787,000 | ||||||||||||
Net income
|
$ | .13 | $ | .15 | $ | .27 | $ | .28 | ||||||||
Diluted:
|
||||||||||||||||
Weighted average shares outstanding
|
302,648,000 | 185,229,000 | 297,364,000 | 184,993,000 | ||||||||||||
Net income
|
$ | .12 | $ | .15 | $ | .25 | $ | .28 |
Common stock and additional
paid-in capital
|
Accumulated other comprehensive
income (loss)
|
Retained earnings (accumulated
deficit)
|
Total
|
|||||||||||||
Balance, December 31, 2008
|
$ | 4,105.9 | $ | (1,770.7 | ) | $ | (705.2 | ) | $ | 1,630.0 | ||||||
Comprehensive income, net of tax:
|
||||||||||||||||
Net income
|
- | - | 52.1 | 52.1 | ||||||||||||
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense of $415.5)
|
- | 745.9 | - | 745.9 | ||||||||||||
Noncredit component of impairment losses on actively managed fixed maturities (net of applicable income tax benefit of $9.2)
|
- | (17.2 | ) | - | (17.2 | ) | ||||||||||
Total comprehensive income
|
780.8 | |||||||||||||||
Stock option and restricted stock plans
|
4.2 | - | - | 4.2 | ||||||||||||
Effect of reclassifying noncredit component of previously recognized impairment losses on actively managed fixed maturities (net of applicable income tax benefit of $2.6)
|
- | (4.9 | ) | 4.9 | - | |||||||||||
Balance, June 30, 2009
|
$ | 4,110.1 | $ | (1,046.9 | ) | $ | (648.2 | ) | $ | 2,415.0 | ||||||
Balance, December 31, 2009
|
$ | 4,411.3 | $ | (264.3 | ) | $ | (614.6 | ) | $ | 3,532.4 | ||||||
Comprehensive income, net of tax:
|
||||||||||||||||
Net income
|
- | - | 67.0 | 67.0 | ||||||||||||
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense of $303.7)
|
- | 553.2 | - | 553.2 | ||||||||||||
Noncredit component of impairment losses on actively managed fixed maturities (net of applicable income tax expense of $20.2)
|
- | 36.1 | - | 36.1 | ||||||||||||
Total comprehensive income
|
656.3 | |||||||||||||||
Cumulative effect of accounting change
|
- | (6.2 | ) | (9.7 | ) | (15.9 | ) | |||||||||
Beneficial conversion feature related to the issuance of convertible debentures
|
4.0 | - | - | 4.0 | ||||||||||||
Stock option and restricted stock plans
|
6.0 | - | - | 6.0 | ||||||||||||
Balance, June 30, 2010
|
$ | 4,421.3 | $ | 318.8 | $ | (557.3 | ) | $ | 4,182.8 |
Six months ended
|
||||||||
June 30,
|
||||||||
2010
|
2009
|
|||||||
Cash flows from operating activities:
|
||||||||
Insurance policy income
|
$ | 1,177.3 | $ | 1,386.5 | ||||
Net investment income
|
667.4 | 584.3 | ||||||
Fee revenue and other income
|
7.1 | 6.1 | ||||||
Insurance policy benefits
|
(997.3 | ) | (1,218.4 | ) | ||||
Interest expense
|
(54.1 | ) | (46.7 | ) | ||||
Policy acquisition costs
|
(210.3 | ) | (205.0 | ) | ||||
Other operating costs
|
(240.2 | ) | (231.9 | ) | ||||
Taxes
|
(3.9 | ) | (5.7 | ) | ||||
Net cash provided by operating activities
|
346.0 | 269.2 | ||||||
Cash flows from investing activities:
|
||||||||
Sales of investments
|
4,572.6 | 5,221.8 | ||||||
Maturities and redemptions of investments
|
392.2 | 434.9 | ||||||
Purchases of investments
|
(5,406.2 | ) | (5,830.5 | ) | ||||
Net sales (purchases) of trading securities
|
(41.5 | ) | 57.4 | |||||
Change in cash and cash equivalents held by variable interest entities
|
(6.3 | ) | 1.1 | |||||
Other
|
(9.2 | ) | (13.4 | ) | ||||
Net cash used by investing activities
|
(498.4 | ) | (128.7 | ) | ||||
Cash flows from financing activities:
|
||||||||
Issuance of notes payable, net
|
110.8 | - | ||||||
Payments on notes payable
|
(116.5 | ) | (59.4 | ) | ||||
Expenses related to debt modification and extinguishment of debt
|
- | (9.5 | ) | |||||
Amounts received for deposit products
|
882.6 | 884.4 | ||||||
Withdrawals from deposit products
|
(862.0 | ) | (949.3 | ) | ||||
Investment borrowings and borrowings related to variable interest entities
|
(62.2 | ) | (19.9 | ) | ||||
Net cash used by financing activities
|
(47.3 | ) | (153.7 | ) | ||||
Net decrease in cash and cash equivalents
|
(199.7 | ) | (13.2 | ) | ||||
Cash and cash equivalents, beginning of period
|
523.4 | 894.5 | ||||||
Cash and cash equivalents, end of period
|
$ | 323.7 | $ | 881.3 | ||||
June 30,
|
December 31,
|
|||||||
2010
|
2009
|
|||||||
Net unrealized appreciation (depreciation) on actively managed fixed maturity securities on which an other-than-temporary impairment loss has been recognized
|
$ | (63.2 | ) | $ | (133.5 | ) | ||
Net unrealized gains (losses) on all other investments
|
697.2 | (339.9 | ) | |||||
Adjustment to value of policies inforce at the Effective Date
|
(20.8 | ) | 10.7 | |||||
Adjustment to cost of policies produced
|
(109.3 | ) | 59.8 | |||||
Unrecognized net loss related to deferred compensation plan
|
(8.0 | ) | (8.2 | ) | ||||
Deferred income tax asset (liability)
|
(177.1 | ) | 146.8 | |||||
Accumulated other comprehensive income (loss)
|
$ | 318.8 | $ | (264.3 | ) |
Other-than-
|
||||||||||||||||||||
temporary
|
||||||||||||||||||||
impairments
|
||||||||||||||||||||
included in
|
||||||||||||||||||||
Gross
|
Gross
|
accumulated other
|
||||||||||||||||||
Amortized
|
unrealized
|
unrealized
|
Estimated
|
comprehensive
|
||||||||||||||||
cost
|
gains
|
losses
|
fair value
|
income (loss)
|
||||||||||||||||
Corporate securities
|
$ | 14,660.3 | $ | 907.3 | $ | (196.4 | ) | $ | 15,371.2 | $ | - | |||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
155.0 | 6.9 | - | 161.9 | - | |||||||||||||||
States and political subdivisions
|
1,300.1 | 32.8 | (43.4 | ) | 1,289.5 | - | ||||||||||||||
Debt securities issued by foreign
governments
|
.9 | .1 | - | 1.0 | - | |||||||||||||||
Asset-backed securities
|
301.8 | 6.3 | (14.6 | ) | 293.5 | (4.8 | ) | |||||||||||||
Collateralized debt obligations
|
144.8 | 1.8 | (3.6 | ) | 143.0 | - | ||||||||||||||
Commercial mortgage-backed securities
|
1,171.8 | 45.1 | (47.9 | ) | 1,169.0 | (3.4 | ) | |||||||||||||
Mortgage pass-through securities
|
34.3 | 1.9 | - | 36.2 | - | |||||||||||||||
Collateralized mortgage obligations
|
1,511.3 | 40.1 | (81.0 | ) | 1,470.4 | (103.5 | ) | |||||||||||||
Total actively managed fixed maturities
|
$ | 19,280.3 | $ | 1,042.3 | $ | (386.9 | ) | $ | 19,935.7 | $ | (111.7 | ) |
Estimated
|
||||||||
Amortized
|
fair
|
|||||||
cost
|
value
|
|||||||
(Dollars in millions)
|
||||||||
Due in one year or less
|
$ | 134.5 | $ | 135.5 | ||||
Due after one year through five years
|
1,041.7 | 1,086.6 | ||||||
Due after five years through ten years
|
4,617.7 | 4,866.0 | ||||||
Due after ten years
|
10,322.4 | 10,735.5 | ||||||
Subtotal
|
16,116.3 | 16,823.6 | ||||||
Structured securities
|
3,164.0 | 3,112.1 | ||||||
Total
|
$ | 19,280.3 | $ | 19,935.7 |
At date of sale
|
||||||||||||
Number
|
Amortized
|
Fair
|
||||||||||
of issuers
|
cost
|
value
|
||||||||||
Less than 6 months prior to sale
|
2 | $ | 18.3 | $ | 14.2 | |||||||
Greater than 12 months prior to sale
|
15 | 127.5 | 69.0 | |||||||||
17 | $ | 145.8 | $ | 83.2 |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Credit losses on actively managed fixed maturity securities, beginning of period
|
$ | (29.4 | ) | $ | (7.4 | ) | $ | (27.2 | ) | $ | (.6 | ) | ||||
Add: credit losses on other-than-temporary impairments not previously recognized
|
(1.3 | ) | (1.6 | ) | (1.3 | ) | (8.4 | ) | ||||||||
Less: credit losses on securities sold
|
10.1 | - | 13.5 | - | ||||||||||||
Less: credit losses on securities impaired due to intent to sell (a)
|
1.1 | - | 1.1 | - | ||||||||||||
Add: credit losses on previously impaired securities
|
(4.5 | ) | (1.0 | ) | (10.1 | ) | (1.0 | ) | ||||||||
Less: increases in cash flows expected on previously impaired securities
|
- | - | - | - | ||||||||||||
Credit losses on actively managed fixed maturity securities, end of period
|
$ | (24.0 | ) | $ | (10.0 | ) | $ | (24.0 | ) | $ | (10.0 | ) |
(a)
|
Represents securities for which the amount previously recognized in accumulated other comprehensive income (loss) was recognized in earnings because we intend to sell the security or we more likely than not will be required to sell the security before recovery of its amortized cost basis.
|
Less than 12 months
|
12 months or greater
|
Total
|
||||||||||||||||||||||
Estimated fair
|
Unrealized
|
Estimated fair
|
Unrealized
|
Estimated fair
|
Unrealized
|
|||||||||||||||||||
Description of securities
|
value
|
losses
|
value
|
losses
|
value
|
losses
|
||||||||||||||||||
Corporate securities
|
$ | 1,138.7 | $ | (43.6 | ) | $ | 1,774.1 | $ | (152.8 | ) | $ | 2,912.8 | $ | (196.4 | ) | |||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
1.0 | - | - | - | 1.0 | - | ||||||||||||||||||
States and political subdivisions
|
146.0 | (3.3 | ) | 262.0 | (40.1 | ) | 408.0 | (43.4 | ) | |||||||||||||||
Asset-backed securities
|
60.7 | (1.7 | ) | 85.1 | (12.9 | ) | 145.8 | (14.6 | ) | |||||||||||||||
Collateralized debt obligations
|
76.6 | (3.6 | ) | - | - | 76.6 | (3.6 | ) | ||||||||||||||||
Commercial mortgage-backed securities
|
132.6 | (5.3 | ) | 147.2 | (42.6 | ) | 279.8 | (47.9 | ) | |||||||||||||||
Mortgage pass-through securities
|
.1 | - | 3.8 | - | 3.9 | - | ||||||||||||||||||
Collateralized mortgage obligations
|
202.2 | (3.0 | ) | 436.3 | (78.0 | ) | 638.5 | (81.0 | ) | |||||||||||||||
Total actively managed fixed maturities
|
$ | 1,757.9 | $ | (60.5 | ) | $ | 2,708.5 | $ | (326.4 | ) | $ | 4,466.4 | $ | (386.9 | ) |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Net income for basic earnings per share
|
$ | 33.1 | $ | 27.6 | $ | 67.0 | $ | 52.1 | ||||||||
Add: interest expense on 7.0% Convertible Senior Debentures due 2016 (the “7.0% Debentures”), net of income taxes
|
3.4 | - | 6.0 | - | ||||||||||||
Net income for diluted earnings per share
|
$ | 36.5 | $ | 27.6 | $ | 73.0 | $ | 52.1 | ||||||||
Shares:
|
||||||||||||||||
Weighted average shares outstanding for basic earnings per share
|
250,994 | 184,820 | 250,891 | 184,787 | ||||||||||||
Effect of dilutive securities on weighted average shares:
|
||||||||||||||||
7% Debentures
|
49,793 | - | 44,663 | - | ||||||||||||
Stock option and restricted stock plans
|
1,861 | 409 | 1,810 | 206 | ||||||||||||
Dilutive potential common shares
|
51,654 | 409 | 46,473 | 206 | ||||||||||||
Weighted average shares outstanding for diluted earnings per share
|
302,648 | 185,229 | 297,364 | 184,993 |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Revenues:
|
||||||||||||||||
Bankers Life:
|
||||||||||||||||
Insurance policy income:
|
||||||||||||||||
Annuities
|
$ | 10.7 | $ | 10.9 | $ | 19.0 | $ | 21.5 | ||||||||
Supplemental health
|
342.4 | 436.5 | 688.3 | 875.2 | ||||||||||||
Life
|
47.6 | 50.2 | 89.6 | 92.4 | ||||||||||||
Net investment income (a)
|
160.5 | 163.6 | 346.4 | 305.8 | ||||||||||||
Fee revenue and other income (a)
|
2.7 | 1.6 | 5.0 | 3.0 | ||||||||||||
Total Bankers Life revenues
|
563.9 | 662.8 | 1,148.3 | 1,297.9 | ||||||||||||
Colonial Penn:
|
||||||||||||||||
Insurance policy income:
|
||||||||||||||||
Supplemental health
|
1.6 | 2.0 | 3.4 | 4.1 | ||||||||||||
Life
|
47.7 | 50.7 | 94.1 | 95.7 | ||||||||||||
Net investment income (a)
|
9.7 | 9.8 | 19.4 | 19.6 | ||||||||||||
Fee revenue and other income (a)
|
.1 | .2 | .3 | .4 | ||||||||||||
Total Colonial Penn revenues
|
59.1 | 62.7 | 117.2 | 119.8 | ||||||||||||
Conseco Insurance Group:
|
||||||||||||||||
Insurance policy income:
|
||||||||||||||||
Annuities
|
2.4 | 10.1 | 4.9 | 23.0 | ||||||||||||
Supplemental health
|
146.9 | 148.7 | 294.2 | 298.1 | ||||||||||||
Life
|
66.7 | 80.1 | 135.2 | 159.9 | ||||||||||||
Other
|
1.9 | 2.1 | 3.8 | 4.2 | ||||||||||||
Net investment income (a)
|
126.3 | 141.1 | 264.3 | 275.4 | ||||||||||||
Fee revenue and other income (a)
|
.2 | .4 | .5 | 1.1 | ||||||||||||
Total Conseco Insurance Group revenues
|
344.4 | 382.5 | 702.9 | 761.7 | ||||||||||||
Corporate operations:
|
||||||||||||||||
Net investment income
|
1.9 | 3.0 | 7.5 | 7.3 | ||||||||||||
Fee and other income
|
.6 | .9 | 1.3 | 1.6 | ||||||||||||
Total corporate revenues
|
2.5 | 3.9 | 8.8 | 8.9 | ||||||||||||
Total revenues
|
969.9 | 1,111.9 | 1,977.2 | 2,188.3 |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Expenses:
|
||||||||||||||||
Bankers Life:
|
||||||||||||||||
Insurance policy benefits
|
$ | 382.7 | $ | 487.1 | $ | 799.2 | $ | 954.3 | ||||||||
Amortization
|
70.6 | 63.1 | 137.6 | 138.7 | ||||||||||||
Other operating costs and expenses
|
46.6 | 49.3 | 94.3 | 96.9 | ||||||||||||
Total Bankers Life expenses
|
499.9 | 599.5 | 1,031.1 | 1,189.9 | ||||||||||||
Colonial Penn:
|
||||||||||||||||
Insurance policy benefits
|
35.4 | 36.2 | 72.1 | 72.6 | ||||||||||||
Amortization
|
8.8 | 8.0 | 17.5 | 16.4 | ||||||||||||
Other operating costs and expenses
|
7.3 | 7.5 | 14.7 | 14.7 | ||||||||||||
Total Colonial Penn expenses
|
51.5 | 51.7 | 104.3 | 103.7 | ||||||||||||
Conseco Insurance Group:
|
||||||||||||||||
Insurance policy benefits
|
232.9 | 257.8 | 478.7 | 507.7 | ||||||||||||
Amortization
|
16.7 | 33.8 | 43.7 | 70.6 | ||||||||||||
Interest expense on investment borrowings
|
5.0 | 5.2 | 10.0 | 10.4 | ||||||||||||
Other operating costs and expenses
|
59.9 | 64.5 | 114.9 | 120.6 | ||||||||||||
Total Conseco Insurance Group expenses
|
314.5 | 361.3 | 647.3 | 709.3 | ||||||||||||
Corporate operations:
|
||||||||||||||||
Interest expense on corporate debt
|
19.8 | 23.9 | 39.3 | 37.6 | ||||||||||||
Interest expense on borrowings of variable interest entities
|
3.9 | 3.6 | 6.9 | 7.9 | ||||||||||||
Loss on extinguishment or modification of debt
|
.9 | - | 2.7 | 9.5 | ||||||||||||
Other operating costs and expenses
|
10.4 | 9.1 | 18.7 | 18.5 | ||||||||||||
Total corporate expenses
|
35.0 | 36.6 | 67.6 | 73.5 | ||||||||||||
Total expenses
|
900.9 | 1,049.1 | 1,850.3 | 2,076.4 | ||||||||||||
Income (loss) before net realized investment losses (net of related amortization) and income taxes:
|
||||||||||||||||
Bankers Life
|
64.0 | 63.3 | 117.2 | 108.0 | ||||||||||||
Colonial Penn
|
7.6 | 11.0 | 12.9 | 16.1 | ||||||||||||
Conseco Insurance Group
|
29.9 | 21.2 | 55.6 | 52.4 | ||||||||||||
Corporate operations
|
(32.5 | ) | (32.7 | ) | (58.8 | ) | (64.6 | ) | ||||||||
Income before net realized investment losses (net of related amortization) and income taxes
|
$ | 69.0 | $ | 62.8 | $ | 126.9 | $ | 111.9 |
(a)
|
It is not practicable to provide additional components of revenue by product or services.
|
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Total segment revenues
|
$ | 969.9 | $ | 1,111.9 | $ | 1,977.2 | $ | 2,188.3 | ||||||||
Net realized investment losses
|
(16.7 | ) | (16.3 | ) | (21.6 | ) | (23.2 | ) | ||||||||
Consolidated revenues
|
$ | 953.2 | $ | 1,095.6 | $ | 1,955.6 | $ | 2,165.1 | ||||||||
Total segment expenses
|
$ | 900.9 | $ | 1,049.1 | $ | 1,850.3 | $ | 2,076.4 | ||||||||
Amortization related to net realized investment losses
|
.5 | (3.1 | ) | .4 | (3.1 | ) | ||||||||||
Consolidated expenses
|
$ | 901.4 | $ | 1,046.0 | $ | 1,850.7 | $ | 2,073.3 |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Current tax expense
|
$ | 1.5 | $ | 1.5 | $ | 2.5 | $ | 3.5 | ||||||||
Deferred tax provision
|
17.2 | 15.9 | 35.4 | 29.2 | ||||||||||||
Income tax expense on period income
|
18.7 | 17.4 | 37.9 | 32.7 | ||||||||||||
Valuation allowance
|
- | 4.6 | - | 7.0 | ||||||||||||
Total income tax expense
|
$ | 18.7 | $ | 22.0 | $ | 37.9 | $ | 39.7 |
Six months ended
|
||||||||
June 30,
|
||||||||
2010
|
2009
|
|||||||
U.S. statutory corporate rate
|
35.0 | % | 35.0 | % | ||||
Valuation allowance
|
- | 7.6 | ||||||
Other nondeductible expenses (benefit)
|
.4 | (1.6 | ) | |||||
State taxes
|
.9 | 1.3 | ||||||
Provision for tax issues, tax credits and other
|
(.2 | ) | .9 | |||||
Effective tax rate
|
36.1 | % | 43.2 | % |
June 30,
|
December 31,
|
|||||||
2010
|
2009
|
|||||||
Deferred tax assets:
|
||||||||
Net federal operating loss carryforwards attributable to:
|
||||||||
Life insurance subsidiaries
|
$ | 731.3 | $ | 745.3 | ||||
Non-life companies
|
874.7 | 883.9 | ||||||
Net state operating loss carryforwards
|
19.0 | 19.1 | ||||||
Tax credits
|
19.9 | 18.5 | ||||||
Capital loss carryforwards
|
387.9 | 393.8 | ||||||
Deductible temporary differences:
|
||||||||
Insurance liabilities
|
774.0 | 782.1 | ||||||
Unrealized depreciation of investments
|
- | 146.8 | ||||||
Other
|
58.4 | 44.0 | ||||||
Gross deferred tax assets
|
2,865.2 | 3,033.5 | ||||||
Deferred tax liabilities:
|
||||||||
Investments
|
(49.1 | ) | (38.1 | ) | ||||
Value of policies inforce at the Effective Date and cost of policies produced
|
(693.8 | ) | (694.0 | ) | ||||
Unrealized appreciation on investments
|
(177.1 | ) | - | |||||
Gross deferred tax liabilities
|
(920.0 | ) | (732.1 | ) | ||||
Net deferred tax assets before valuation allowance
|
1,945.2 | 2,301.4 | ||||||
Valuation allowance
|
(1,176.4 | ) | (1,176.4 | ) | ||||
Net deferred tax assets
|
768.8 | 1,125.0 | ||||||
Current income taxes prepaid (accrued)
|
.2 | (1.0 | ) | |||||
Income tax assets, net
|
$ | 769.0 | $ | 1,124.0 |
Year of expiration
|
Net operating loss carryforwards (a)
|
Capital loss
|
Total loss
|
|||||||||||||||
Life
|
Non-life
|
carryforwards
|
carryforwards
|
|||||||||||||||
2010
|
$ | - | $ | .1 | $ | - | $ | .1 | ||||||||||
2011
|
- | .1 | - | .1 | ||||||||||||||
2012
|
- | - | 46.7 | 46.7 | ||||||||||||||
2013
|
- | - | 1,034.2 | 1,034.2 | ||||||||||||||
2014
|
- | - | 27.3 | 27.3 | ||||||||||||||
2018
|
1,855.9 |
(a)
|
- | - | 1,855.9 | |||||||||||||
2021
|
29.6 | - | - | 29.6 | ||||||||||||||
2022
|
204.1 | - | - | 204.1 | ||||||||||||||
2023
|
- | 2,034.1 |
(a)
|
- | 2,034.1 | |||||||||||||
2024
|
- | 3.2 | - | 3.2 | ||||||||||||||
2025
|
- | 118.8 | - | 118.8 | ||||||||||||||
2027
|
- | 215.8 | - | 215.8 | ||||||||||||||
2028
|
- | 1.2 | - | 1.2 | ||||||||||||||
2029
|
- | 125.9 | - | 125.9 | ||||||||||||||
Total
|
$ | 2,089.6 | $ | 2,499.2 | $ | 1,108.2 | $ | 5,697.0 |
(a)
|
The allocation of the NOLs summarized above assumes the IRS does not take an adverse position in the future regarding the tax position we plan to take in our tax returns with respect to the allocation of cancellation of indebtedness income. If the IRS disagrees with the tax position we plan to take with respect to the allocation of cancellation of indebtedness income, and their position prevails, approximately $631 million of the NOLs expiring in 2018 would be characterized as non-life NOLs.
|
June 30,
|
December 31,
|
|||||||
2010
|
2009
|
|||||||
3.5% Convertible Debentures due September 30, 2035 (the “3.5% Debentures”)
|
$ | - | $ | 116.5 | ||||
7.0% Debentures
|
293.0 | 176.5 | ||||||
Secured credit agreement
|
652.1 | 652.1 | ||||||
Senior Note due November 12, 2013 (the “Senior Note”)
|
100.0 | 100.0 | ||||||
Unamortized discount on 3.5% Debentures
|
- | (3.3 | ) | |||||
Unamortized discount on 7.0% Debentures
|
(15.7 | ) | (4.4 | ) | ||||
Direct corporate obligations
|
$ | 1,029.4 | $ | 1,037.4 |
Balance or
|
||||||
ratio as of
|
Margin for adverse
|
|||||
Covenant under the
|
June 30,
|
development from
|
||||
Senior Credit Agreement
|
2010
|
June 30, 2010 levels
|
||||
Aggregate risk-based capital ratio
|
Greater than or equal to 200% through December 31, 2010; greater than or equal to 225% from March 31, 2011 through December 31, 2011; and thereafter, greater than 250%.
|
318% |
Reduction to total adjusted capital (defined as combined statutory capital and surplus plus the asset valuation reserve and 50 percent of the balance of the provision of policyholder dividends) of approximately $555 million, or an increase to required risk-based capital of approximately $277 million.
|
|||
Combined statutory capital and surplus
|
Greater than $1,100 million through December 31, 2010; greater than $1,200 million from March 31, 2011 through December 31, 2011; and thereafter, $1,300 million.
|
$1,496 million
|
Reduction to combined statutory capital and surplus of approximately $396 million.
|
|||
Debt to total capitalization ratio
|
Not more than 30%.
|
21% |
Reduction to shareholders’ equity of approximately $1.4 billion or additional debt of $609 million.
|
|||
Interest coverage ratio
|
Greater than or equal to 1.50 to 1 for rolling four quarters through December 31, 2010; greater than or equal to 1.75 to 1 for rolling four quarters from March 31, 2011 through December 31, 2011; and thereafter, 2.00 to 1.
|
1.76 to 1
|
Reduction in cash flows to the holding company of approximately $19 million.
|
Remainder of 2010
|
$ | 25.0 | ||
2011
|
60.0 | |||
2012
|
65.0 | |||
2013
|
602.1 | |||
2016
|
293.0 | |||
$ | 1,045.1 |
Amount
|
Maturity
|
Interest rate
|
||
borrowed
|
date
|
at June 30, 2010
|
||
$ | 54.0 |
May 2012
|
Variable rate – 0.484%
|
|
37.0 |
July 2012
|
Fixed rate – 5.540%
|
||
13.0 |
July 2012
|
Variable rate – 0.354%
|
||
146.0 |
November 2015
|
Fixed rate – 5.300%
|
||
100.0 |
November 2015
|
Fixed rate – 4.890%
|
||
100.0 |
December 2015
|
Fixed rate – 4.710%
|
Balance at December 31, 2009
|
250,786
|
|
Shares issued under employee benefit compensation plans
|
259
|
(a)
|
Balance at June 30, 2010
|
251,045
|
(a)
|
Such amount was reduced by 72 thousand shares which were tendered for the payment of federal and state taxes owed on the issuance of restricted stock.
|
January 1, 2010
|
||||||||||||
Amounts prior to effect of adoption of authoritative
|
Effect of adoption of authoritative
|
As
|
||||||||||
guidance
|
guidance
|
adjusted
|
||||||||||
Total investments
|
$ | 21,530.2 | $ | 247.6 | $ | 21,777.8 | ||||||
Cash and cash equivalents held by variable interest entities
|
3.4 | 3.8 | 7.2 | |||||||||
Accrued investment income
|
309.0 | .9 | 309.9 | |||||||||
Income tax assets, net
|
1,124.0 | 8.6 | 1,132.6 | |||||||||
Other assets
|
310.7 | 14.2 | 324.9 | |||||||||
Total assets
|
30,343.8 | 275.1 | 30,618.9 | |||||||||
Other liabilities
|
610.4 | 8.8 | 619.2 | |||||||||
Borrowings related to variable interest entities
|
229.1 | 282.2 | 511.3 | |||||||||
Total liabilities
|
26,811.4 | 291.0 | 27,102.4 | |||||||||
Accumulated other comprehensive income (loss)
|
(264.3 | ) | (6.2 | ) | (270.5 | ) | ||||||
Accumulated deficit
|
(614.6 | ) | (9.7 | ) | (624.3 | ) | ||||||
Total shareholders’ equity
|
3,532.4 | (15.9 | ) | 3,516.5 | ||||||||
Total liabilities and shareholders’ equity
|
30,343.8 | 275.1 | 30,618.9 |
Six months ended
|
||||||||
June 30,
|
||||||||
2010
|
2009
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$ | 67.0 | $ | 52.1 | ||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Amortization and depreciation
|
214.0 | 241.2 | ||||||
Income taxes
|
34.0 | 34.0 | ||||||
Insurance liabilities
|
197.5 | 128.6 | ||||||
Accrual and amortization of investment income
|
29.8 | (23.8 | ) | |||||
Deferral of policy acquisition costs
|
(210.3 | ) | (205.0 | ) | ||||
Net realized investment losses
|
21.6 | 23.2 | ||||||
Loss on extinguishment or modification of debt
|
2.7 | 9.5 | ||||||
Other
|
(10.3 | ) | 9.4 | |||||
Net cash provided by operating activities
|
$ | 346.0 | $ | 269.2 |
Six months ended
|
||||||||
June 30,
|
||||||||
2010
|
2009
|
|||||||
Stock option and restricted stock plans
|
$ | 6.0 | $ | 4.2 | ||||
Change in securities lending collateral
|
103.7 | 141.5 | ||||||
Change in securities lending payable
|
(103.7 | ) | (141.5 | ) |
June 30, 2010
|
||||||||||||
Fall Creek
|
Net effect on
|
|||||||||||
and
|
consolidated
|
|||||||||||
Eagle Creek
|
Eliminations
|
balance sheet
|
||||||||||
Assets:
|
||||||||||||
Investments held by variable interest entities
|
$ | 478.4 | $ | - | $ | 478.4 | ||||||
Notes receivable of VIEs held by insurance subsidiaries
|
- | (96.8 | ) | (96.8 | ) | |||||||
Cash and cash equivalents held by variable interest entities
|
13.5 | - | 13.5 | |||||||||
Accrued investment income
|
1.7 | (3.9 | ) | (2.2 | ) | |||||||
Income tax assets, net
|
25.0 | (6.5 | ) | 18.5 | ||||||||
Other assets
|
20.0 | - | 20.0 | |||||||||
Total assets
|
$ | 538.6 | $ | (107.2 | ) | $ | 431.4 | |||||
Liabilities:
|
||||||||||||
Other liabilities
|
$ | 19.6 | $ | (3.7 | ) | $ | 15.9 | |||||
Borrowings related to variable interest entities
|
449.7 | - | 449.7 | |||||||||
Notes payable of VIEs held by insurance subsidiaries
|
115.6 | (115.6 | ) | - | ||||||||
Total liabilities
|
$ | 584.9 | $ | (119.3 | ) | $ | 465.6 |
December 31, 2009
|
||||||||||||
Net effect on
|
||||||||||||
consolidated
|
||||||||||||
Fall Creek
|
Eliminations
|
balance sheet
|
||||||||||
Assets:
|
||||||||||||
Actively managed fixed maturities
|
$ | 268.0 | $ | - | $ | 268.0 | ||||||
Notes receivable of VIE held by insurance subsidiaries
|
- | (81.9 | ) | (81.9 | ) | |||||||
Cash and cash equivalents – restricted
|
3.4 | - | 3.4 | |||||||||
Accrued investment income
|
1.2 | (3.0 | ) | (1.8 | ) | |||||||
Income tax assets, net
|
19.3 | (5.3 | ) | 14.0 | ||||||||
Other assets
|
8.0 | - | 8.0 | |||||||||
Total assets
|
$ | 299.9 | $ | (90.2 | ) | $ | 209.7 | |||||
Liabilities:
|
||||||||||||
Other liabilities
|
$ | 7.7 | $ | (3.2 | ) | $ | 4.5 | |||||
Investment borrowings
|
229.1 | - | 229.1 | |||||||||
Notes payable of VIE held by insurance subsidiaries
|
99.2 | (99.2 | ) | - | ||||||||
Total liabilities
|
$ | 336.0 | $ | (102.4 | ) | $ | 233.6 |
Estimated
|
||||||||
Amortized
|
fair
|
|||||||
cost
|
value
|
|||||||
(Dollars in millions)
|
||||||||
Due in one year or less
|
$ | 5.7 | $ | 5.8 | ||||
Due after one year through five years
|
420.1 | 401.6 | ||||||
Due after five years through ten years
|
71.5 | 71.0 | ||||||
Total
|
$ | 497.3 | $ | 478.4 |
At date of sale
|
||||||||||||
Number
|
Amortized
|
Fair
|
||||||||||
of issuers
|
cost
|
value
|
||||||||||
Greater than or equal to 6 and less than 12 months prior to sale
|
2 | $ | .3 | $ | .1 | |||||||
Greater than 12 months prior to sale
|
4 | 2.0 | 1.2 | |||||||||
6 | $ | 2.3 | $ | 1.3 |
·
|
Level 1 – includes assets and liabilities valued using inputs that are quoted prices in active markets for identical assets or liabilities. Our Level 1 assets include exchange traded securities.
|
·
|
Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data. Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs such as interest rate, credit spread, reported trades, broker/dealer quotes, issuer spreads and other inputs that are observable or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; and non-exchange-traded derivatives such as call options to hedge liabilities related to our equity-indexed annuity products.
|
·
|
Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions. Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on non-binding broker prices or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information. Financial instruments in this category include certain corporate securities (primarily private placements), certain mortgage and asset-backed securities, and other less liquid securities. Additionally, the Company’s liabilities for embedded derivatives (including embedded derivatives related to our equity-indexed annuity products and to a modified coinsurance arrangement) are classified in Level 3 since their values include significant unobservable inputs including actuarial assumptions.
|
Quoted prices in active markets for identical assets or liabilities
(Level 1)
|
Significant other observable inputs
(Level 2)
|
Significant unobservable inputs
(Level 3)
|
Total
|
|||||||||||||||
Assets:
|
||||||||||||||||||
Actively managed fixed maturities:
|
||||||||||||||||||
Corporate securities
|
$ | - | $ | 12,917.6 | $ | 2,453.6 | $ | 15,371.2 | ||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
19.5 | 140.3 | 2.1 | 161.9 | ||||||||||||||
States and political subdivisions
|
- | 1,279.5 | 10.0 | 1,289.5 | ||||||||||||||
Asset-backed securities
|
- | .9 | 6.1 | 7.0 | ||||||||||||||
Collateralized debt obligations
|
- | 287.5 | 136.8 | 424.3 | ||||||||||||||
Commercial mortgage-backed securities
|
- | 6.1 | 10.5 | 16.6 | ||||||||||||||
Mortgage pass-through securities
|
32.3 | 1,158.6 | 3.9 | 1,194.8 | ||||||||||||||
Collateralized mortgage obligations
|
- | 1,446.3 | 24.1 | 1,470.4 | ||||||||||||||
Total actively managed fixed maturities
|
51.8 | 17,236.8 | 2,647.1 | 19,935.7 | ||||||||||||||
Equity securities
|
- | - | 31.0 | 31.0 | ||||||||||||||
Trading securities:
|
||||||||||||||||||
Corporate securities
|
8.6 | 49.1 | 4.1 | 61.8 | ||||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
- | 283.2 | - | 283.2 | ||||||||||||||
States and political subdivisions
|
- | 7.9 | - | 7.9 | ||||||||||||||
Asset-backed securities
|
- | .6 | - | .6 | ||||||||||||||
Commercial mortgage-backed securities
|
- | 5.0 | - | 5.0 | ||||||||||||||
Mortgage pass-through securities
|
.4 | - | - | .4 | ||||||||||||||
Collateralized mortgage obligations
|
- | 1.8 | - | 1.8 | ||||||||||||||
Total trading securities
|
9.0 | 347.6 | 4.1 | 360.7 | ||||||||||||||
Investments held by variable interest entities
|
- | 471.2 | 7.2 | 478.4 | ||||||||||||||
Securities lending collateral:
|
||||||||||||||||||
Corporate securities
|
- | 21.0 | - | 21.0 | ||||||||||||||
Asset-backed securities
|
- | 14.7 | 4.9 | 19.6 | ||||||||||||||
Total securities lending collateral
|
- | 35.7 | 4.9 | 40.6 | ||||||||||||||
Other invested assets
|
- | 121.3 |
(a)
|
- | 121.3 | |||||||||||||
Assets held in separate accounts
|
- | 15.6 | - | 15.6 | ||||||||||||||
Liabilities:
|
||||||||||||||||||
Liabilities for insurance products:
|
||||||||||||||||||
Interest-sensitive products
|
- | - | 500.5 |
(b)
|
500.5 |
(a)
|
Includes company-owned life insurance and derivatives.
|
(b)
|
Includes $500.2 million of embedded derivatives associated with our equity-indexed annuity products and $.3 million of embedded derivatives associated with a modified coinsurance agreement.
|
Quoted prices in active markets for identical assets or liabilities
(Level 1)
|
Significant other observable inputs
(Level 2)
|
Significant unobservable inputs
(Level 3)
|
Total
|
|||||||||||||||
Assets:
|
||||||||||||||||||
Actively managed fixed maturities:
|
||||||||||||||||||
Corporate securities
|
$ | - | $ | 12,044.3 | $ | 2,247.1 | $ | 14,291.4 | ||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
19.4 | 248.0 | 2.2 | 269.6 | ||||||||||||||
States and political subdivisions
|
- | 842.9 | 10.7 | 853.6 | ||||||||||||||
Debt securities issued by foreign governments
|
- | 5.1 | - | 5.1 | ||||||||||||||
Asset-backed securities
|
- | 176.3 | 15.8 | 192.1 | ||||||||||||||
Collateralized debt obligations
|
- | - | 92.8 | 92.8 | ||||||||||||||
Commercial mortgage-backed securities
|
- | 752.3 | 13.7 | 766.0 | ||||||||||||||
Mortgage pass-through securities
|
37.1 | 1.3 | 4.2 | 42.6 | ||||||||||||||
Collateralized mortgage obligations
|
- | 2,003.8 | 11.4 | 2,015.2 | ||||||||||||||
Total actively managed fixed maturities
|
56.5 | 16,074.0 | 2,397.9 | 18,528.4 | ||||||||||||||
Equity securities
|
.1 | - | 30.9 | 31.0 | ||||||||||||||
Trading securities:
|
||||||||||||||||||
Corporate securities
|
3.8 | 49.4 | 3.7 | 56.9 | ||||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
- | 220.3 | - | 220.3 | ||||||||||||||
States and political subdivisions
|
- | 4.4 | - | 4.4 | ||||||||||||||
Asset-backed securities
|
- | .6 | - | .6 | ||||||||||||||
Commercial mortgage-backed securities
|
- | 4.9 | - | 4.9 | ||||||||||||||
Mortgage pass-through securities
|
.5 | - | - | .5 | ||||||||||||||
Collateralized mortgage obligations
|
- | 5.7 | - | 5.7 | ||||||||||||||
Total trading securities
|
4.3 | 285.3 | 3.7 | 293.3 | ||||||||||||||
Securities lending collateral:
|
||||||||||||||||||
Corporate securities
|
- | 81.0 | 13.7 | 94.7 | ||||||||||||||
Asset-backed securities
|
- | 16.2 | 22.9 | 39.1 | ||||||||||||||
Total securities lending collateral
|
- | 97.2 | 36.6 | 133.8 | ||||||||||||||
Other invested assets
|
- | 192.6 |
(a)
|
2.4 |
(b)
|
195.0 | ||||||||||||
Assets held in separate accounts
|
- | 17.3 | - | 17.3 | ||||||||||||||
Liabilities:
|
||||||||||||||||||
Liabilities for insurance products:
|
||||||||||||||||||
Interest-sensitive products
|
- | - | 496.0 |
(c)
|
496.0 |
|
____________
|
(a)
|
Includes company-owned life insurance and derivatives.
|
(b)
|
Includes equity-like holdings in special-purpose entities.
|
(c)
|
Includes $494.4 million of embedded derivatives associated with our equity-indexed annuity products and $1.6 million of embedded derivatives associated with a modified coinsurance agreement.
|
June 30, 2010
|
||||||||||||||||||||||||||||||||
Beginning
balance
as of
March 31,
2010
|
Purchases,
sales,
issuances
and
settlements,
net
|
Total
realized
and
unrealized
gains
(losses)
included
in net
income
|
Total realized
and unrealized
gains (losses)
included in
accumulated other
comprehensive
income (loss)
|
Transfers
into
Level 3
|
Transfers
out of
Level 3 (b)
|
Ending
balance
as of
June 30,
2010
|
Amount of total gains (losses) for the three months ended
June 30, 2010 included
in our net
income relating
to assets and liabilities still held as of the reporting date
|
|||||||||||||||||||||||||
Assets:
|
||||||||||||||||||||||||||||||||
Actively managed fixed maturities:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
$ | 2,248.6 | $ | 83.6 | $ | .8 | $ | 102.8 | $ | 33.4 | $ | (15.6 | ) | $ | 2,453.6 | $ | - | |||||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
2.2 | (.1 | ) | - | - | - | - | 2.1 | - | |||||||||||||||||||||||
States and political subdivisions
|
8.9 | - | - | 1.1 | - | - | 10.0 | - | ||||||||||||||||||||||||
Asset-backed securities
|
6.3 | (.4 | ) | - | .2 | - | - | 6.1 | - | |||||||||||||||||||||||
Collateralized debt obligations
|
128.9 | 11.2 | (.8 | ) | (2.5 | ) | - | - | 136.8 | - | ||||||||||||||||||||||
Commercial mortgage-backed securities
|
- | - | - | - | 10.5 | - | 10.5 | - | ||||||||||||||||||||||||
Mortgage pass-through securities
|
3.9 | (.1 | ) | - | .1 | - | - | 3.9 | - | |||||||||||||||||||||||
Collateralized mortgage obligations
|
9.9 | 23.8 | - | - | - | (9.6 | ) | 24.1 | - | |||||||||||||||||||||||
Total actively managed fixed maturities
|
2,408.7 | 118.0 | - | 101.7 | 43.9 | (25.2 | ) | 2,647.1 | - | |||||||||||||||||||||||
Equity securities
|
31.0 | - | - | - | - | - | 31.0 | - | ||||||||||||||||||||||||
Trading securities:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
4.0 | - | - | (.4 | ) | .5 | - | 4.1 | (.4 | ) | ||||||||||||||||||||||
Investments held by variable interest entities:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
7.1 | - | - | .1 | - | - | 7.2 | - | ||||||||||||||||||||||||
Securities lending collateral:
|
||||||||||||||||||||||||||||||||
Asset-backed securities
|
21.4 | (15.6 | ) | (.2 | ) | .3 | - | (1.0 | ) | 4.9 | (.2 | ) | ||||||||||||||||||||
Other invested assets
|
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||
Liabilities:
|
||||||||||||||||||||||||||||||||
Liabilities for insurance products:
|
||||||||||||||||||||||||||||||||
Interest-sensitive products
|
(497.2 | ) | 29.4 | (32.7 | ) | - | - | - | (500.5 | ) | (32.7 | ) |
June 30, 2010
|
||||||||||||||||||||||||||||||||||||
Beginning
balance
as of
December 31,
2009
|
Cumulative
effect of
accounting
change (a)
|
Purchases,
sales,
issuances
and
settlements,
net
|
Total
realized
and
unrealized
gains
(losses)
included
in net
income
|
Total realized
and unrealized
gains (losses)
included in accumulated other
comprehensive
income (loss)
|
Transfers
Into
Level 3
|
Transfers
out of
Level 3 (b)
|
Ending
balance
as of
June 30,
2010
|
Amount of total gains (losses) for the six months ended
June 30, 2010 included
in our net
income relating
to assets and liabilities still held as of the reporting date
|
||||||||||||||||||||||||||||
Assets:
|
||||||||||||||||||||||||||||||||||||
Actively managed fixed maturities:
|
||||||||||||||||||||||||||||||||||||
Corporate securities
|
$ | 2,247.1 | $ | (5.9 | ) | $ | 76.6 | $ | .8 | $ | 119.0 | $ | 47.0 | $ | (31.0 | ) | $ | 2,453.6 | $ | - | ||||||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
2.2 | - | (.1 | ) | - | - | - | - | 2.1 | - | ||||||||||||||||||||||||||
States and political subdivisions
|
10.7 | - | - | - | 1.1 | - | (1.8 | ) | 10.0 | - | ||||||||||||||||||||||||||
Asset-backed securities
|
15.8 | - | (11.5 | ) | (11.3 | ) | 13.1 | - | - | 6.1 | - | |||||||||||||||||||||||||
Collateralized debt obligations
|
92.8 | (5.7 | ) | 50.1 | (.2 | ) | (.2 | ) | - | - | 136.8 | - | ||||||||||||||||||||||||
Commercial mortgage-backed securities
|
13.7 | - | (.7 | ) | - | 2.0 | 1.3 | (5.8 | ) | 10.5 | - | |||||||||||||||||||||||||
Mortgage pass-through securities
|
4.2 | - | (.3 | ) | - | - | - | - | 3.9 | - | ||||||||||||||||||||||||||
Collateralized mortgage obligations
|
11.4 | - | 23.8 | - | - | - | (11.1 | ) | 24.1 | - | ||||||||||||||||||||||||||
Total actively managed fixed maturities
|
2,397.9 | (11.6 | ) | 137.9 | (10.7 | ) | 135.0 | 48.3 | (49.7 | ) | 2,647.1 | - | ||||||||||||||||||||||||
Equity securities
|
30.9 | - | .1 | - | - | - | - | 31.0 | - | |||||||||||||||||||||||||||
Trading securities:
|
||||||||||||||||||||||||||||||||||||
Corporate securities
|
3.7 | - | - | - | - | .4 | - | 4.1 | - | |||||||||||||||||||||||||||
Investments held by variable interest entities:
|
||||||||||||||||||||||||||||||||||||
Corporate securities
|
- | 6.9 | - | - | .3 | - | - | 7.2 | - | |||||||||||||||||||||||||||
Securities lending collateral:
|
||||||||||||||||||||||||||||||||||||
Corporate securities
|
13.7 | - | (13.7 | ) | - | - | - | - | - | - | ||||||||||||||||||||||||||
Asset-backed securities
|
22.9 | - | (15.5 | ) | (.2 | ) | (.3 | ) | - | (2.0 | ) | 4.9 | (.2 | ) | ||||||||||||||||||||||
Total securities lending collateral
|
36.6 | - | (29.2 | ) | (.2 | ) | (.3 | ) | - | (2.0 | ) | 4.9 | (.2 | ) | ||||||||||||||||||||||
Other invested assets
|
2.4 | (2.4 | ) | - | - | - | - | - | - | - | ||||||||||||||||||||||||||
Liabilities:
|
||||||||||||||||||||||||||||||||||||
Liabilities for insurance products:
|
||||||||||||||||||||||||||||||||||||
Interest-sensitive products
|
(496.0 | ) | - | 35.0 | (39.5 | ) | - | - | - | (500.5 | ) | (39.5 | ) |
(a)
|
Amounts represent adjustments to investments related to a variable interest entity that was required to be consolidated effective January 1, 2010, as well as the reclassification of investments of a variable interest entity which was consolidated at December 31, 2009.
|
(b)
|
Transfers out of Level 3 are reported as having occurred at the beginning of the period.
|
June 30, 2009
|
||||||||||||||||||||||||||||||||
Beginning
balance
as of
March 31,
2009
|
Purchases,
sales,
issuances
and
settlements,
net
|
Total
realized
and
unrealized
gains
(losses)
included
in net
income
|
Total realized
and unrealized
gains (losses)
included in accumulated other
comprehensive
income (loss)
|
Transfers
into
Level 3
|
Transfers
out of
Level 3
|
Ending
balance
as of
June 30,
2009
|
Amount of total gains (losses) for the three months ended
June 30, 2009 included
in our net
income relating
to assets and liabilities still held as of the reporting date
|
|||||||||||||||||||||||||
Assets:
|
||||||||||||||||||||||||||||||||
Actively managed fixed maturities:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
$ | 1,802.5 | $ | 61.0 | $ | (1.0 | ) | $ | 11.2 | $ | - | $ | (21.2 | ) | $ | 1,852.5 | $ | (1.0 | ) | |||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
2.4 | - | - | (.1 | ) | - | - | 2.3 | - | |||||||||||||||||||||||
States and political subdivisions
|
9.0 | (.1 | ) | - | - | - | - | 8.9 | - | |||||||||||||||||||||||
Asset-backed securities
|
23.6 | (.7 | ) | - | .3 | - | - | 23.2 | - | |||||||||||||||||||||||
Collateralized debt obligations
|
102.1 | (2.0 | ) | - | 4.8 | - | - | 104.9 | - | |||||||||||||||||||||||
Commercial mortgage-backed securities
|
7.2 | - | - | - | - | (7.2 | ) | - | - | |||||||||||||||||||||||
Mortgage pass-through securities
|
4.6 | (.2 | ) | - | - | - | - | 4.4 | - | |||||||||||||||||||||||
Collateralized mortgage obligations
|
.3 | - | - | - | - | - | .3 | - | ||||||||||||||||||||||||
Total actively managed fixed maturities
|
1,951.7 | 58.0 | (1.0 | ) | 16.2 | - | (28.4 | ) | 1,996.5 | (1.0 | ) | |||||||||||||||||||||
Equity securities
|
32.5 | - | - | (.9 | ) | - | (1.2 | ) | 30.4 | - | ||||||||||||||||||||||
Trading securities:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
2.7 | - | - | .4 | - | (.4 | ) | 2.7 | .4 | |||||||||||||||||||||||
Securities lending collateral:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
9.9 | - | - | - | 13.6 | - | 23.5 | - | ||||||||||||||||||||||||
Equity securities
|
.1 | (.1 | ) | - | - | - | - | - | - | |||||||||||||||||||||||
Asset-backed securities
|
25.5 | - | (.6 | ) | .2 | 1.0 | (7.6 | ) | 18.5 | (.7 | ) | |||||||||||||||||||||
Total securities lending collateral
|
35.5 | (.1 | ) | (.6 | ) | .2 | 14.6 | (7.6 | ) | 42.0 | (.7 | ) | ||||||||||||||||||||
Other invested assets
|
2.8 | - | - | (1.9 | ) | .- | - | .9 | - | |||||||||||||||||||||||
Liabilities:
|
||||||||||||||||||||||||||||||||
Liabilities for insurance products:
|
||||||||||||||||||||||||||||||||
Interest-sensitive products
|
(404.0 | ) | (16.0 | ) | 13.4 | - | - | - | (406.6 | ) | 13.4 |
June 30, 2009
|
||||||||||||||||||||||||||||||||
Beginning
balance
as of
December 31,
2008
|
Purchases,
sales,
issuances
and
settlements,
net
|
Total
realized
and
unrealized
gains
(losses)
included
in net
income
|
Total realized
and unrealized
gains (losses)
included in
accumulated other
comprehensive
income (loss)
|
Transfers
into
Level 3
|
Transfers
out of
Level 3
|
Ending
balance
as of
June 30,
2009
|
Amount of total gains (losses) for the six months ended
June 30, 2009 included
in our net
income relating
to assets and liabilities still held as of the reporting date
|
|||||||||||||||||||||||||
Assets:
|
||||||||||||||||||||||||||||||||
Actively managed fixed maturities:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
$ | 1,715.6 | $ | 86.3 | $ | (4.0 | ) | $ | 54.8 | $ | 5.9 | $ | (6.1 | ) | $ | 1,852.5 | $ | (4.0 | ) | |||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
2.6 | - | - | (.3 | ) | - | - | 2.3 | - | |||||||||||||||||||||||
States and political subdivisions
|
10.5 | (.3 | ) | - | (1.3 | ) | - | - | 8.9 | - | ||||||||||||||||||||||
Asset-backed securities
|
27.5 | (1.6 | ) | - | - | - | (2.7 | ) | 23.2 | - | ||||||||||||||||||||||
Collateralized debt obligations
|
96.7 | (2.2 | ) | (2.7 | ) | 13.1 | - | - | 104.9 | (2.7 | ) | |||||||||||||||||||||
Commercial mortgage-backed securities
|
9.6 | (3.7 | ) | (.6 | ) | 1.7 | - | (7.0 | ) | - | - | |||||||||||||||||||||
Mortgage pass-through securities
|
4.9 | (.5 | ) | - | - | - | - | 4.4 | - | |||||||||||||||||||||||
Collateralized mortgage obligations
|
8.7 | (.1 | ) | - | (.1 | ) | - | (8.2 | ) | .3 | - | |||||||||||||||||||||
Total actively managed fixed maturities
|
1,876.1 | 77.9 | (7.3 | ) | 67.9 | 5.9 | (24.0 | ) | 1,996.5 | (6.7 | ) | |||||||||||||||||||||
Equity securities
|
32.4 | (.3 | ) | - | (1.7 | ) | - | - | 30.4 | - | ||||||||||||||||||||||
Trading securities:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
2.7 | - | - | - | - | - | 2.7 | - | ||||||||||||||||||||||||
Securities lending collateral:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
34.9 | (7.0 | ) | - | .1 | - | (4.4 | ) | 23.6 | - | ||||||||||||||||||||||
Equity securities
|
.1 | (.1 | ) | (.2 | ) | .2 | - | - | - | (.2 | ) | |||||||||||||||||||||
Asset-backed securities
|
13.1 | - | (.7 | ) | (.2 | ) | 6.2 | - | 18.4 | (.7 | ) | |||||||||||||||||||||
Total securities lending collateral
|
48.1 | (7.1 | ) | (.9 | ) | .1 | 6.2 | (4.4 | ) | 42.0 | (.9 | ) | ||||||||||||||||||||
Other invested assets
|
2.3 | - | (3.4 | ) | 2.0 | - | - | .9 | (3.4 | ) | ||||||||||||||||||||||
Liabilities:
|
||||||||||||||||||||||||||||||||
Liabilities for insurance products:
|
||||||||||||||||||||||||||||||||
Interest-sensitive products
|
(437.2 | ) | 19.1 | 11.5 | - | - | - | (406.6 | ) | 11.5 |
June 30, 2010
|
December 31, 2009
|
|||||||||||||||
Carrying
|
Estimated fair
|
Carrying
|
Estimated fair
|
|||||||||||||
amount
|
value
|
amount
|
value
|
|||||||||||||
Financial assets:
|
||||||||||||||||
Actively managed fixed maturities
|
$ | 19,935.7 | $ | 19,935.7 | $ | 18,528.4 | $ | 18,528.4 | ||||||||
Equity securities
|
31.0 | 31.0 | 31.0 | 31.0 | ||||||||||||
Mortgage loans
|
1,948.1 | 1,923.1 | 1,965.5 | 1,756.8 | ||||||||||||
Policy loans
|
292.9 | 292.9 | 295.2 | 295.2 | ||||||||||||
Trading securities
|
360.7 | 360.7 | 293.3 | 293.3 | ||||||||||||
Investments held by securitization
entities
|
478.4 | 478.4 | - | - | ||||||||||||
Securities lending collateral
|
77.6 | 77.6 | 180.0 | 180.0 | ||||||||||||
Other invested assets
|
167.2 | 167.2 | 236.8 | 236.8 | ||||||||||||
Cash and cash equivalents
|
337.2 | 337.2 | 526.8 | 526.8 | ||||||||||||
Financial liabilities:
|
||||||||||||||||
Insurance liabilities for interest-sensitive products (a)
|
13,177.8 | 13,177.8 | $ | 13,219.2 | $ | 13,219.2 | ||||||||||
Investment borrowings
|
454.2 | 510.6 | 683.9 | 677.6 | ||||||||||||
Borrowings related to securitization
entities
|
449.7 | 400.1 | - | - | ||||||||||||
Notes payable – direct corporate obligations
|
1,029.4 | 1,061.3 | 1,037.4 | 1,041.7 |
(a)
|
The estimated fair value of insurance liabilities for interest-sensitive products was approximately equal to its carrying value at June 30, 2010 and December 31, 2009. This was because interest rates credited on the vast majority of account balances approximate current rates paid on similar products and because these rates are not generally guaranteed beyond one year.
|
ITEM 2.
|
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
|
·
|
our ability to continue to satisfy the financial ratio and balance requirements and other covenants of our debt agreements;
|
·
|
general economic, market and political conditions, including the performance and fluctuations of the financial markets which may affect our ability to raise capital or refinance existing indebtedness and the cost of doing so;
|
·
|
our ability to generate sufficient liquidity to meet our debt service obligations and other cash needs;
|
·
|
our ability to obtain adequate and timely rate increases on our supplemental health products, including our long-term care business;
|
·
|
the receipt of any required regulatory approvals for dividend and surplus debenture interest payments from our insurance subsidiaries;
|
·
|
mortality, morbidity, the increased cost and usage of health care services, persistency, the adequacy of our previous reserve estimates and other factors which may affect the profitability of our insurance products;
|
·
|
changes in our assumptions related to the cost of policies produced or the value of policies inforce at the Effective Date;
|
·
|
the recoverability of our deferred tax assets and the effect of potential ownership changes and tax rate changes on its value;
|
·
|
our assumption that the positions we take on our tax return filings, including our position that our 7.0% Debentures will not be treated as stock for purposes of Section 382 of the Code and will not trigger an ownership change, will not be successfully challenged by the IRS;
|
·
|
changes in accounting principles and the interpretation thereof;
|
·
|
our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems;
|
·
|
performance and valuation of our investments, including the impact of realized losses (including other-than-temporary impairment charges);
|
·
|
our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition;
|
·
|
the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject;
|
·
|
our ability to complete the remediation of the material weakness in internal controls over our actuarial reporting process and to maintain effective controls over financial reporting;
|
·
|
our ability to continue to recruit and retain productive agents and distribution partners and customer response to new products, distribution channels and marketing initiatives;
|
·
|
our ability to achieve eventual upgrades of the financial strength ratings of CNO and our insurance company subsidiaries as well as the impact of rating downgrades on our business and our ability to access capital;
|
·
|
the risk factors or uncertainties listed from time to time in our filings with the SEC;
|
·
|
regulatory changes or actions, including those relating to regulation of the financial affairs of our insurance companies, such as the payment of dividends and surplus debenture interest to us, regulation of financial services affecting (among other things) bank sales and underwriting of insurance products, regulation of the sale, underwriting and pricing of products, and health care regulation affecting health insurance products; and
|
·
|
changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products.
|
·
|
Bankers Life,
which consists primarily of the business of Bankers Life, markets and distributes health and life insurance products and annuities to the middle-income senior market through a dedicated field force of career agents and sales managers supported by a network of community-based branch offices. Products include Medicare supplement insurance, life insurance, fixed annuities and long-term care insurance. Bankers Life also markets and distributes Medicare Part D prescription drug plans through a distribution and reinsurance arrangement with Coventry and Medicare Advantage plans primarily through a distribution arrangement with Humana.
|
·
|
Colonial Penn
, which consists primarily of the business of Colonial Penn Life Insurance Company (“Colonial Penn”), markets primarily graded benefit and simplified issue life insurance directly to customers through television advertising, direct mail, the internet and telemarketing. Colonial Penn markets its products under its own brand name.
|
·
|
Conseco Insurance Group,
which markets and distributes specified disease insurance, accident, disability, life insurance and annuities to middle-income consumers at home and at the worksite. These products are marketed through Performance Matters Associates, Inc., a wholly owned subsidiary, and through independent marketing organizations and insurance agencies. Products being marketed by Conseco Insurance Group are underwritten by Conseco Insurance Company, Conseco Health Insurance Company (“Conseco Health”) and Washington National. This segment also includes blocks of long-term care and other insurance business, in these companies and in Conseco Life, which we no longer market. Later in 2010, the Company expects to disaggregate the Conseco Insurance Group segment into two segments which will be referred to as Washington National and Other CNO Business. The Washington National segment will be comprised of the active blocks of business of the Conseco Insurance Group segment while the Other CNO Business segment will be comprised primarily of the closed blocks of business currently included in the Conseco Insurance Group segment.
|
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Earnings before net realized investment gains (losses), corporate interest expense, loss on extinguishment or modification of debt and income taxes (“EBIT” a non-GAAP financial measure) (a):
|
||||||||||||||||
Bankers Life
|
$ | 64.0 | $ | 63.3 | $ | 117.2 | $ | 108.0 | ||||||||
Colonial Penn
|
7.6 | 11.0 | 12.9 | 16.1 | ||||||||||||
Conseco Insurance Group
|
29.9 | 21.2 | 55.6 | 52.4 | ||||||||||||
Corporate Operations, excluding corporate interest expense
|
(11.8 | ) | (8.8 | ) | (16.8 | ) | (17.5 | ) | ||||||||
EBIT
|
89.7 | 86.7 | 168.9 | 159.0 | ||||||||||||
Corporate interest expense
|
(19.8 | ) | (23.9 | ) | (39.3 | ) | (37.6 | ) | ||||||||
Income before loss on extinguishment or modification of debt, net realized investment losses and taxes
|
69.9 | 62.8 | 129.6 | 121.4 | ||||||||||||
Tax expense on operating income
|
25.0 | 22.0 | 46.5 | 43.1 | ||||||||||||
Net operating income
|
44.9 | 40.8 | 83.1 | 78.3 | ||||||||||||
Loss on extinguishment or modification of debt, net of income taxes
|
(.6 | ) | - | (1.8 | ) | (6.1 | ) | |||||||||
Net realized investment losses (net of related amortization and taxes and the establishment of a valuation allowance for deferred tax assets related to such losses)
|
(11.2 | ) | (13.2 | ) | (14.3 | ) | (20.1 | ) | ||||||||
Net income applicable to common stock
|
$ | 33.1 | $ | 27.6 | $ | 67.0 | $ | 52.1 | ||||||||
Per diluted share:
|
||||||||||||||||
Net operating income
|
$ | .16 | $ | .22 | $ | .30 | $ | .42 | ||||||||
Loss on extinguishment or modification of debt, net of income taxes
|
- | - | - | (.03 | ) | |||||||||||
Net realized investment losses, net of related amortization and taxes
|
(.04 | ) | (.07 | ) | (.05 | ) | (.11 | ) | ||||||||
Net income
|
$ | .12 | $ | .15 | $ | .25 | $ | .28 |
(a)
|
Management believes that an analysis of EBIT provides a clearer comparison of the operating results of the Company from period to period because it excludes: (i) corporate interest expense; (ii) loss on extinguishment or modification of debt; and (iii) net realized investment gains (losses) that are unrelated to the Company’s underlying fundamentals. The table above reconciles the non-GAAP measure to the corresponding GAAP measure.
|
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Income (loss) before net realized investment gains (losses), net of related amortization, and income taxes (a non-GAAP measure) (a):
|
||||||||||||||||
Bankers Life
|
$ | 64.0 | $ | 63.3 | $ | 117.2 | $ | 108.0 | ||||||||
Colonial Penn
|
7.6 | 11.0 | 12.9 | 16.1 | ||||||||||||
Conseco Insurance Group
|
29.9 | 21.2 | 55.6 | 52.4 | ||||||||||||
Corporate operations
|
(32.5 | ) | (32.7 | ) | (58.8 | ) | (64.6 | ) | ||||||||
69.0 | 62.8 | 126.9 | 111.9 | |||||||||||||
Net realized investment gains (losses), net of related amortization:
|
||||||||||||||||
Bankers Life
|
(9.8 | ) | (13.3 | ) | (13.3 | ) | (15.7 | ) | ||||||||
Colonial Penn
|
- | 1.1 | .5 | 1.2 | ||||||||||||
Conseco Insurance Group
|
(6.0 | ) | (3.2 | ) | (6.5 | ) | - | |||||||||
Corporate operations
|
(1.4 | ) | 2.2 | (2.7 | ) | (5.6 | ) | |||||||||
(17.2 | ) | (13.2 | ) | (22.0 | ) | (20.1 | ) | |||||||||
Income (loss) before income taxes:
|
||||||||||||||||
Bankers Life
|
54.2 | 50.0 | 103.9 | 92.3 | ||||||||||||
Colonial Penn
|
7.6 | 12.1 | 13.4 | 17.3 | ||||||||||||
Conseco Insurance Group
|
23.9 | 18.0 | 49.1 | 52.4 | ||||||||||||
Corporate operations
|
(33.9 | ) | (30.5 | ) | (61.5 | ) | (70.2 | ) | ||||||||
Income before income taxes
|
$ | 51.8 | $ | 49.6 | $ | 104.9 | $ | 91.8 |
(a)
|
These non-GAAP measures as presented in the above table and in the following segment financial data and discussions of segment results exclude net realized investment gains (losses), net of related amortization and before income taxes. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company’s performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
|
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Premium collections:
|
||||||||||||||||
Annuities
|
$ | 281.1 | $ | 275.4 | $ | 505.3 | $ | 577.5 | ||||||||
Supplemental health
|
332.4 | 422.0 | 679.5 | 845.8 | ||||||||||||
Life
|
52.1 | 55.3 | 98.6 | 104.2 | ||||||||||||
Total collections
|
$ | 665.6 | $ | 752.7 | $ | 1,283.4 | $ | 1,527.5 | ||||||||
Average liabilities for insurance products:
|
||||||||||||||||
Annuities:
|
||||||||||||||||
Mortality based
|
$ | 250.7 | $ | 250.7 | $ | 251.2 | $ | 251.8 | ||||||||
Equity-indexed
|
1,769.7 | 1,464.4 | 1,727.4 | 1,445.4 | ||||||||||||
Deposit based
|
4,905.5 | 4,754.7 | 4,905.4 | 4,716.4 | ||||||||||||
Health
|
4,337.4 | 4,090.0 | 4,306.6 | 4,070.2 | ||||||||||||
Life:
|
||||||||||||||||
Interest sensitive
|
412.2 | 399.4 | 410.0 | 398.5 | ||||||||||||
Non-interest sensitive
|
346.9 | 415.0 | 339.2 | 405.8 | ||||||||||||
Total average liabilities for insurance products, net of reinsurance ceded
|
$ | 12,022.4 | $ | 11,374.2 | $ | 11,939.8 | $ | 11,288.1 | ||||||||
Revenues:
|
||||||||||||||||
Insurance policy income
|
$ | 400.7 | $ | 497.6 | $ | 796.9 | $ | 989.1 | ||||||||
Net investment income:
|
||||||||||||||||
General account invested assets
|
177.0 | 160.2 | 349.2 | 315.6 | ||||||||||||
Equity-indexed products
|
(15.3 | ) | (2.5 | ) | (3.2 | ) | (16.0 | ) | ||||||||
Other special-purpose portfolios
|
(1.2 | ) | 5.9 | .4 | 6.2 | |||||||||||
Fee revenue and other income
|
2.7 | 1.6 | 5.0 | 3.0 | ||||||||||||
Total revenues
|
563.9 | 662.8 | 1,148.3 | 1,297.9 | ||||||||||||
Expenses:
|
||||||||||||||||
Insurance policy benefits
|
344.2 | 422.9 | 694.8 | 852.5 | ||||||||||||
Amounts added to policyholder account balances:
|
||||||||||||||||
Annuity products and interest-sensitive life products other than equity-indexed products
|
44.1 | 48.2 | 87.9 | 94.1 | ||||||||||||
Equity-indexed products
|
(5.6 | ) | 16.0 | 16.5 | 7.7 | |||||||||||
Amortization related to operations
|
70.6 | 63.1 | 137.6 | 138.7 | ||||||||||||
Other operating costs and expenses
|
46.6 | 49.3 | 94.3 | 96.9 | ||||||||||||
Total benefits and expenses
|
499.9 | 599.5 | 1,031.1 | 1,189.9 | ||||||||||||
Income before net realized investment losses, net of related amortization, and income taxes
|
64.0 | 63.3 | 117.2 | 108.0 | ||||||||||||
Net realized investment losses
|
(10.3 | ) | (14.9 | ) | (13.3 | ) | (16.8 | ) | ||||||||
Amortization related to net realized investment losses
|
.5 | 1.6 | - | 1.1 | ||||||||||||
Net realized investment losses, net of related amortization
|
(9.8 | ) | (13.3 | ) | (13.3 | ) | (15.7 | ) | ||||||||
Income before income taxes
|
$ | 54.2 | $ | 50.0 | $ | 103.9 | $ | 92.3 |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Health benefit ratios:
|
||||||||||||||||
All health lines:
|
||||||||||||||||
Insurance policy benefits
|
$ | 302.9 | $ | 382.6 | $ | 614.7 | $ | 772.7 | ||||||||
Benefit ratio (a)
|
88.4 | % | 87.7 | % | 89.3 | % | 88.3 | % | ||||||||
Medicare supplement:
|
||||||||||||||||
Insurance policy benefits
|
$ | 126.2 | $ | 113.6 | $ | 256.4 | $ | 229.6 | ||||||||
Benefit ratio (a)
|
70.7 | % | 68.6 | % | 71.8 | % | 69.4 | % | ||||||||
PDP:
|
||||||||||||||||
Insurance policy benefits
|
$ | 17.7 | $ | 20.9 | $ | 33.7 | $ | 44.5 | ||||||||
Benefit ratio (a)
|
89.8 | % | 97.1 | % | 89.3 | % | 96.3 | % | ||||||||
PFFS:
|
||||||||||||||||
Insurance policy benefits
|
$ | (4.3 | ) | $ | 91.3 | $ | (9.4 | ) | $ | 183.4 | ||||||
Benefit ratio (a)
|
N/A | 93.7 | % | N/A | 93.9 | % | ||||||||||
Long-term care:
|
||||||||||||||||
Insurance policy benefits
|
$ | 163.3 | $ | 156.8 | $ | 334.0 | $ | 315.2 | ||||||||
Benefit ratio (a)
|
113.0 | % | 103.2 | % | 113.7 | % | 104.1 | % | ||||||||
Interest-adjusted benefit ratio (b)
|
71.9 | % | 66.4 | % | 73.6 | % | 67.5 | % |
(a)
|
We calculate
benefit
ratios by dividing the related product’s insurance policy benefits by insurance policy income.
|
(b)
|
We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for Bankers Life’s long-term care products by dividing such product’s insurance policy benefits less interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company’s performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
|
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Expenses related to the marketing and quota-share agreements with Coventry
|
$ | 2.3 | $ | 6.7 | $ | 8.1 | $ | 14.7 | ||||||||
Commission expense
|
4.0 | 4.6 | 8.3 | 8.6 | ||||||||||||
Other operating expenses
|
40.3 | 38.0 | 77.9 | 73.6 | ||||||||||||
Total
|
$ | 46.6 | $ | 49.3 | $ | 94.3 | $ | 96.9 |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Premium collections:
|
||||||||||||||||
Life
|
$ | 46.7 | $ | 45.8 | $ | 94.0 | $ | 92.8 | ||||||||
Supplemental health
|
1.7 | 2.1 | 3.3 | 4.0 | ||||||||||||
Total collections
|
$ | 48.4 | $ | 47.9 | $ | 97.3 | $ | 96.8 | ||||||||
Average liabilities for insurance products:
|
||||||||||||||||
Annuities-mortality based
|
$ | 79.3 | $ | 82.1 | $ | 79.6 | $ | 82.7 | ||||||||
Health
|
17.7 | 19.2 | 17.9 | 19.4 | ||||||||||||
Life:
|
||||||||||||||||
Interest sensitive
|
21.6 | 23.3 | 21.7 | 23.7 | ||||||||||||
Non-interest sensitive
|
578.2 | 569.1 | 577.4 | 568.9 | ||||||||||||
Total average liabilities for insurance products, net of reinsurance ceded
|
$ | 696.8 | $ | 693.7 | $ | 696.6 | $ | 694.7 | ||||||||
Revenues:
|
||||||||||||||||
Insurance policy income
|
$ | 49.3 | $ | 52.7 | $ | 97.5 | $ | 99.8 | ||||||||
Net investment income:
|
||||||||||||||||
General account invested assets
|
9.7 | 9.8 | 19.4 | 19.6 | ||||||||||||
Fee revenue and other income
|
.1 | .2 | .3 | .4 | ||||||||||||
Total revenues
|
59.1 | 62.7 | 117.2 | 119.8 | ||||||||||||
Expenses:
|
||||||||||||||||
Insurance policy benefits
|
35.2 | 36.0 | 71.6 | 72.1 | ||||||||||||
Amounts added to annuity and interest-sensitive life product account balances
|
.2 | .2 | .5 | .5 | ||||||||||||
Amortization related to operations
|
8.8 | 8.0 | 17.5 | 16.4 | ||||||||||||
Other operating costs and expenses
|
7.3 | 7.5 | 14.7 | 14.7 | ||||||||||||
Total benefits and expenses
|
51.5 | 51.7 | 104.3 | 103.7 | ||||||||||||
Income before net realized investment gains and income taxes
|
7.6 | 11.0 | 12.9 | 16.1 | ||||||||||||
Net realized investment gains
|
- | 1.1 | .5 | 1.2 | ||||||||||||
Income before income taxes
|
$ | 7.6 | $ | 12.1 | $ | 13.4 | $ | 17.3 |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Premium collections:
|
||||||||||||||||
Annuities
|
$ | 4.2 | $ | 22.3 | $ | 9.3 | $ | 41.8 | ||||||||
Supplemental health
|
148.1 | 149.3 | 297.9 | 295.5 | ||||||||||||
Life
|
50.7 | 62.4 | 105.3 | 126.8 | ||||||||||||
Total collections
|
$ | 203.0 | $ | 234.0 | $ | 412.5 | $ | 464.1 | ||||||||
Average liabilities for insurance products:
|
||||||||||||||||
Annuities:
|
||||||||||||||||
Mortality based
|
$ | 210.9 | $ | 215.8 | $ | 211.5 | $ | 216.5 | ||||||||
Equity-indexed
|
728.1 | 773.6 | 735.8 | 805.1 | ||||||||||||
Deposit based
|
659.6 | 669.6 | 639.8 | 679.2 | ||||||||||||
Separate accounts
|
16.3 | 17.7 | 16.7 | 17.6 | ||||||||||||
Health
|
2,965.6 | 3,003.5 | 2,988.3 | 2,997.7 | ||||||||||||
Life:
|
||||||||||||||||
Interest sensitive
|
2,593.7 | 2,860.8 | 2,600.5 | 2,883.5 | ||||||||||||
Non-interest sensitive
|
1,046.4 | 1,344.9 | 1,049.0 | 1,352.6 | ||||||||||||
Total average liabilities for insurance products, net of reinsurance ceded
|
$ | 8,220.6 | $ | 8,885.9 | $ | 8,241.6 | $ | 8,952.2 | ||||||||
Revenues:
|
||||||||||||||||
Insurance policy income
|
$ | 217.9 | $ | 241.0 | $ | 438.1 | $ | 485.2 | ||||||||
Net investment income:
|
||||||||||||||||
General account invested assets
|
134.3 | 138.5 | 267.6 | 281.9 | ||||||||||||
Equity-indexed products
|
(6.5 | ) | (.4 | ) | (2.6 | ) | (7.4 | ) | ||||||||
Trading account income related to policyholder and reinsurer accounts
|
(.5 | ) | 5.7 | 1.2 | 3.4 | |||||||||||
Change in value of embedded derivatives related to modified coinsurance agreements
|
(1.0 | ) | (2.7 | ) | (1.9 | ) | (2.5 | ) | ||||||||
Fee revenue and other income
|
.2 | .4 | .5 | 1.1 | ||||||||||||
Total revenues
|
344.4 | 382.5 | 702.9 | 761.7 | ||||||||||||
Expenses:
|
||||||||||||||||
Insurance policy benefits
|
200.9 | 215.1 | 403.6 | 429.2 | ||||||||||||
Amounts added to policyholder account balances:
|
||||||||||||||||
Annuity products and interest-sensitive life products other than equity-indexed products
|
31.5 | 35.8 | 64.0 | 71.8 | ||||||||||||
Equity-indexed products
|
.5 | 6.9 | 11.1 | 6.7 | ||||||||||||
Amortization related to operations
|
16.7 | 33.8 | 43.7 | 70.6 | ||||||||||||
Interest expense on investment borrowings
|
5.0 | 5.2 | 10.0 | 10.4 | ||||||||||||
Other operating costs and expenses
|
59.9 | 64.5 | 114.9 | 120.6 | ||||||||||||
Total benefits and expenses
|
314.5 | 361.3 | 647.3 | 709.3 | ||||||||||||
Income (loss) before net realized investment gains (losses), net of related amortization, and income taxes
|
29.9 | 21.2 | 55.6 | 52.4 | ||||||||||||
Net realized investment gains (losses)
|
(5.0 | ) | (4.7 | ) | (6.1 | ) | (2.0 | ) | ||||||||
Amortization related to net realized investment gains (losses)
|
(1.0 | ) | 1.5 | (.4 | ) | 2.0 | ||||||||||
Net realized investment gains (losses), net of related amortization
|
(6.0 | ) | (3.2 | ) | (6.5 | ) | - | |||||||||
Income before income taxes
|
$ | 23.9 | $ | 18.0 | $ | 49.1 | $ | 52.4 |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Health benefit ratios:
|
||||||||||||||||
All health lines:
|
||||||||||||||||
Insurance policy benefits
|
$ | 126.2 | $ | 128.9 | $ | 250.6 | $ | 251.6 | ||||||||
Benefit ratio (a)
|
84.8 | % | 85.5 | % | 84.1 | % | 83.2 | % | ||||||||
Medicare supplement:
|
||||||||||||||||
Insurance policy benefits
|
$ | 26.4 | $ | 32.7 | $ | 53.8 | $ | 64.6 | ||||||||
Benefit ratio (a)
|
65.8 | % | 71.2 | % | 65.8 | % | 69.3 | % | ||||||||
Specified disease:
|
||||||||||||||||
Insurance policy benefits
|
$ | 82.5 | $ | 78.9 | $ | 163.1 | $ | 150.2 | ||||||||
Benefit ratio (a)
|
83.2 | % | 83.3 | % | 82.8 | % | 79.7 | % | ||||||||
Interest-adjusted benefit ratio (b)
|
52.0 | % | 49.7 | % | 50.7 | % | 46.0 | % | ||||||||
Long-term care:
|
||||||||||||||||
Insurance policy benefits
|
$ | 16.0 | $ | 14.8 | $ | 30.4 | $ | 32.2 | ||||||||
Benefit ratio (a)
|
212.9 | % | 182.2 | % | 199.9 | % | 196.3 | % | ||||||||
Interest-adjusted benefit ratio (b)
|
128.0 | % | 103.1 | % | 112.2 | % | 117.7 | % | ||||||||
Other:
|
||||||||||||||||
Insurance policy benefits
|
$ | 1.3 | $ | 2.5 | $ | 3.3 | $ | 4.6 | ||||||||
Benefit ratio (a)
|
67.3 | % | 120.4 | % | 86.1 | % | 109.5 | % |
(a)
|
We calculate
benefit
ratios by dividing the related product’s insurance policy benefits by insurance policy income.
|
(b)
|
We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for Conseco Insurance Group’s specified disease and long-term care products by dividing such product’s insurance policy benefits less interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company’s performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
|
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Corporate operations:
|
||||||||||||||||
Interest expense on corporate debt
|
$ | (19.8 | ) | $ | (23.9 | ) | $ | (39.3 | ) | $ | (37.6 | ) | ||||
Net investment income (loss):
|
||||||||||||||||
General account invested assets
|
.1 | - | .1 | .2 | ||||||||||||
Other special-purpose portfolios
|
(3.2 | ) | (.5 | ) | (3.0 | ) | (.7 | ) | ||||||||
Fee revenue and other income
|
.4 | .8 | .9 | 1.4 | ||||||||||||
Net operating results of variable interest entities
|
1.1 | (.1 | ) | 3.5 | (.1 | ) | ||||||||||
Loss on extinguishment or modification of debt
|
(.9 | ) | - | (2.7 | ) | (9.5 | ) | |||||||||
Other operating costs and expenses
|
(10.2 | ) | (9.0 | ) | (18.3 | ) | (18.3 | ) | ||||||||
Loss before net realized investment gains (losses) and income taxes
|
(32.5 | ) | (32.7 | ) | (58.8 | ) | (64.6 | ) | ||||||||
Net realized investment gains (losses)
|
(1.4 | ) | 2.2 | (2.7 | ) | (5.6 | ) | |||||||||
Loss before income taxes
|
$ | (33.9 | ) | $ | (30.5 | ) | $ | (61.5 | ) | $ | (70.2 | ) |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Premiums collected by product:
|
||||||||||||||||
Annuities:
|
||||||||||||||||
Equity-indexed (first-year)
|
$ | 146.9 | $ | 90.8 | $ | 250.9 | $ | 163.9 | ||||||||
Other fixed (first-year)
|
133.1 | 183.9 | 252.2 | 411.9 | ||||||||||||
Other fixed (renewal)
|
1.1 | .7 | 2.2 | 1.7 | ||||||||||||
Subtotal - other fixed annuities
|
134.2 | 184.6 | 254.4 | 413.6 | ||||||||||||
Total annuities
|
281.1 | 275.4 | 505.3 | 577.5 | ||||||||||||
Supplemental health:
|
||||||||||||||||
Medicare supplement (first-year)
|
29.4 | 21.1 | 56.6 | 40.8 | ||||||||||||
Medicare supplement (renewal)
|
139.4 | 134.1 | 288.8 | 270.2 | ||||||||||||
Subtotal - Medicare supplement
|
168.8 | 155.2 | 345.4 | 311.0 | ||||||||||||
Long-term care (first-year)
|
5.5 | 4.7 | 10.3 | 8.9 | ||||||||||||
Long-term care (renewal)
|
141.1 | 147.2 | 285.8 | 288.9 | ||||||||||||
Subtotal - long-term care
|
146.6 | 151.9 | 296.1 | 297.8 | ||||||||||||
PDP and PFFS (first year)
|
.7 | 22.2 | 2.1 | 38.4 | ||||||||||||
PDP and PFFS (renewal)
|
13.4 | 89.7 | 30.1 | 192.7 | ||||||||||||
Subtotal – PDP and PFFS
|
14.1 | 111.9 | 32.2 | 231.1 | ||||||||||||
Other health (first-year)
|
.5 | .7 | 1.1 | 1.3 | ||||||||||||
Other health (renewal)
|
2.4 | 2.3 | 4.7 | 4.6 | ||||||||||||
Subtotal - other health
|
2.9 | 3.0 | 5.8 | 5.9 | ||||||||||||
Total supplemental health
|
332.4 | 422.0 | 679.5 | 845.8 | ||||||||||||
Life insurance:
|
||||||||||||||||
First-year
|
24.8 | 19.4 | 45.0 | 36.2 | ||||||||||||
Renewal
|
27.3 | 35.9 | 53.6 | 68.0 | ||||||||||||
Total life insurance
|
52.1 | 55.3 | 98.6 | 104.2 | ||||||||||||
Collections on insurance products:
|
||||||||||||||||
Total first-year premium collections on insurance products
|
340.9 | 342.8 | 618.2 | 701.4 | ||||||||||||
Total renewal premium collections on insurance products
|
324.7 | 409.9 | 665.2 | 826.1 | ||||||||||||
Total collections on insurance products
|
$ | 665.6 | $ | 752.7 | $ | 1,283.4 | $ | 1,527.5 |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Premiums collected by product:
|
||||||||||||||||
Life insurance:
|
||||||||||||||||
First-year
|
$ | 8.l | $ | 8.4 | $ | 16.0 | $ | 17.6 | ||||||||
Renewal
|
38.6 | 37.4 | 78.0 | 75.2 | ||||||||||||
Total life insurance
|
46.7 | 45.8 | 94.0 | 92.8 | ||||||||||||
Supplemental health (all of which are renewal premiums):
|
||||||||||||||||
Medicare supplement
|
1.6 | 1.9 | 3.1 | 3.6 | ||||||||||||
Other health
|
.1 | .2 | .2 | .4 | ||||||||||||
Total supplemental health
|
1.7 | 2.1 | 3.3 | 4.0 | ||||||||||||
Collections on insurance products:
|
||||||||||||||||
Total first-year premium collections on insurance products
|
8.1 | 8.4 | 16.0 | 17.6 | ||||||||||||
Total renewal premium collections on insurance products
|
40.3 | 39.5 | 81.3 | 79.2 | ||||||||||||
Total collections on insurance products
|
$ | 48.4 | $ | 47.9 | $ | 97.3 | $ | 96.8 |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Premiums collected by product:
|
||||||||||||||||
Annuities:
|
||||||||||||||||
Equity-indexed (first-year)
|
$ | 2.0 | $ | 20.5 | $ | 5.5 | $ | 38.2 | ||||||||
Equity-indexed (renewal)
|
1.5 | 1.4 | 2.7 | 2.8 | ||||||||||||
Subtotal - equity-indexed annuities
|
3.5 | 21.9 | 8.2 | 41.0 | ||||||||||||
Other fixed (first-year)
|
.5 | .1 | .7 | .2 | ||||||||||||
Other fixed (renewal)
|
.2 | .3 | .4 | .6 | ||||||||||||
Subtotal - other fixed annuities
|
.7 | .4 | 1.1 | .8 | ||||||||||||
Total annuities
|
4.2 | 22.3 | 9.3 | 41.8 | ||||||||||||
Supplemental health:
|
||||||||||||||||
Medicare supplement (first-year)
|
1.1 | 1.9 | 2.3 | 3.4 | ||||||||||||
Medicare supplement (renewal)
|
37.6 | 42.5 | 77.1 | 83.8 | ||||||||||||
Subtotal - Medicare supplement
|
38.7 | 44.4 | 79.4 | 87.2 | ||||||||||||
Specified disease (first-year)
|
13.1 | 11.1 | 25.6 | 21.3 | ||||||||||||
Specified disease (renewal)
|
87.1 | 84.0 | 174.2 | 166.8 | ||||||||||||
Subtotal - specified disease
|
100.2 | 95.1 | 199.8 | 188.1 | ||||||||||||
Long-term care (all of which are renewal)
|
7.5 | 8.0 | 15.2 | 16.4 | ||||||||||||
Other health (all of which are renewal)
|
1.7 | 1.8 | 3.5 | 3.8 | ||||||||||||
Total supplemental health
|
148.1 | 149.3 | 297.9 | 295.5 | ||||||||||||
Life insurance:
|
||||||||||||||||
First-year
|
.8 | .5 | 1.6 | 1.0 | ||||||||||||
Renewal
|
49.9 | 61.9 | 103.7 | 125.8 | ||||||||||||
Total life insurance
|
50.7 | 62.4 | 105.3 | 126.8 | ||||||||||||
Collections on insurance products:
|
||||||||||||||||
Total first-year premium collections on insurance products
|
17.5 | 34.1 | 35.7 | 64.1 | ||||||||||||
Total renewal premium collections on insurance products
|
185.5 | 199.9 | 376.8 | 400.0 | ||||||||||||
Total collections on insurance products
|
$ | 203.0 | $ | 234.0 | $ | 412.5 | $ | 464.1 |
June 30,
|
December 31,
|
|||||||
2010
|
2009
|
|||||||
Total capital:
|
||||||||
Corporate notes payable
|
$ | 1,029.4 | $ | 1,037.4 | ||||
Shareholders’ equity:
|
||||||||
Common stock
|
2.5 | 2.5 | ||||||
Additional paid-in capital
|
4,418.8 | 4,408.8 | ||||||
Accumulated other comprehensive income (loss)
|
318.8 | (264.3 | ) | |||||
Accumulated deficit
|
(557.3 | ) | (614.6 | ) | ||||
Total shareholders’ equity
|
4,182.8 | 3,532.4 | ||||||
Total capital
|
$ | 5,212.2 | $ | 4,569.8 | ||||
June 30,
|
December 31,
|
|||||||
2010
|
2009
|
|||||||
Book value per common share
|
$ | 16.66 | $ | 14.09 | ||||
Book value per common share, excluding accumulated other comprehensive income (loss) (a)
|
15.39 | 15.14 | ||||||
Ratio of earnings to fixed charges
|
1.49 | X | 1.38 | X | ||||
Debt to total capital ratios:
|
||||||||
Corporate debt to total capital (b)
|
20 | % | 23 | % | ||||
Corporate debt to total capital, excluding accumulated other comprehensive income (loss) (a)
|
21 | % | 21 | % |
(a)
|
This non-GAAP measure differs from the corresponding GAAP measure presented immediately above, because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive income (loss). Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management. However, this measure does not replace the corresponding GAAP measure.
|
(b)
|
Such ratio differs from the debt to total capitalization ratio required by our Senior Credit Agreement, primarily because the credit agreement ratio excludes accumulated other comprehensive income (loss) from total capital.
|
Amount
|
Maturity
|
Interest rate
|
|||
borrowed
|
date
|
at June 30, 2010
|
|||
$ | 54.0 |
May 2012
|
Variable rate – 0.484%
|
||
37.0 |
July 2012
|
Fixed rate – 5.540%
|
|||
13.0 |
July 2012
|
Variable rate – 0.354%
|
|||
146.0 |
November 2015
|
Fixed rate – 5.300%
|
|||
100.0 |
November 2015
|
Fixed rate – 4.890%
|
|||
100.0 |
December 2015
|
Fixed rate – 4.710%
|
Earned surplus
|
|||||
Subsidiary of CDOC
|
(deficit) (a)
|
Additional information
|
|||
Conseco Life of Texas
|
$ | (1,252.4 | ) |
(b)
|
|
Washington National
|
(1,187.7 | ) |
(c)
|
||
Conseco Health
|
(5.6 | ) |
(a)
|
As calculated pursuant to the state insurance department of each company’s domiciliary state.
|
(b)
|
During 2008, Conseco Life of Texas transferred the ownership of Senior Health, Washington National and Conseco Health to CDOC. As a result of this transaction, the $1,574.7 million of accumulated unrealized losses of Conseco Life of Texas’ former subsidiaries were realized by Conseco Life of Texas, reducing its earned surplus to $(1,206.4) million at December 31, 2008, pursuant to the manner earned surplus is calculated under the regulations of the Texas Department of Insurance.
|
(c)
|
Pursuant to the regulations of the Illinois Division of Insurance, the accumulated earnings and losses of Washington National’s subsidiaries are reflected in the earned surplus of Washington National. The deficit is largely due to the accumulated losses of Washington National’s subsidiaries.
|
Earned surplus
|
|||||
Subsidiary of CDOC
|
(deficit) (a)
|
Additional information
|
|||
Subsidiaries of Conseco Life of Texas:
|
|||||
Bankers Life
|
$ | 163.7 |
(b)
|
||
Colonial Penn
|
(234.7 | ) |
(c)
|
||
Subsidiaries of Washington National:
|
|||||
Conseco Insurance Company
|
(6.8 | ) |
(d)
|
||
Conseco Life
|
(402.2 | ) |
(e)
|
(a)
|
As calculated pursuant to the state insurance department of each company’s domiciliary state.
|
(b)
|
Bankers Life’s ability to pay ordinary dividends is currently limited to its statutory net income in 2009 of $86.7 million.
|
(c)
|
The deficit is primarily due to transactions which occurred several years ago, including a tax planning transaction and the fee paid to recapture a block of business previously ceded to an unaffiliated insurer.
|
(d)
|
Conseco Insurance Company will not be able to pay ordinary dividends until its future earnings result in a positive earned surplus balance.
|
(e)
|
We have no plans for Conseco Life to pay dividends to Washington National at any time in the foreseeable future.
|
·
|
the receipt of any required approval for dividend payments and surplus debenture interest payments from our insurance subsidiaries by the director or commissioner of the applicable state insurance departments when required and our ability to make such payments;
|
·
|
the potential adverse effects on CNO’s businesses from downgrades by rating agencies;
|
·
|
our ability to achieve our operating plan;
|
·
|
the potential for future declines in the bond and commercial mortgage loan markets and the potential for further significant recognition of other-than-temporary impairments;
|
·
|
the potential need to provide additional capital to our insurance subsidiaries;
|
·
|
our ability to continue to achieve compliance with our loan covenants including the financial ratios we are required to maintain;
|
·
|
the potential loss of key personnel that could impair our ability to achieve our operating plan;
|
·
|
the potential impact of an ownership change or a decrease in our operating earnings on the valuation allowance related to our deferred tax assets; and
|
·
|
the potential impact on the RBC ratio of our insurance subsidiaries if regulators do not modify the calculation of the required capital for commercial mortgages based on the use of the mortgage experience adjustment factor in a manner that results in a capital requirement that is the same or similar to the requirement calculated pursuant to temporary modifications effective for 2009 and 2010;
|
·
|
the potential impact on the RBC ratio of our insurance subsidiaries if regulators do not modify the calculation of the required capital for investments in RMBS in a manner that results in a capital requirement that is the same or similar to the requirement calculated pursuant to temporary modifications effective for 2009 and 2010; and
|
·
|
the potential impact on certain of CNO’s insurance subsidiaries if regulators do not allow us to continue to recognize certain deferred tax assets pursuant to temporary modifications in statutory prescribed practices effective for 2009 and 2010.
|
Remainder of 2010
|
$ | 25.0 | ||
2011
|
60.0 | |||
2012
|
65.0 | |||
2013
|
602.1 | |||
2016
|
293.0 | |||
$ | 1,045.1 |
From our operations or surplus debenture
interest payments
|
From extraordinary dividends requiring
approval
|
Total
|
||||||||||
Sources of holding company cash:
|
||||||||||||
Dividends from our insurance subsidiaries:
|
||||||||||||
Conseco Life of Texas
|
$ | - | $ | 150.0 | $ | 150.0 | ||||||
Washington National
|
- | 20.0 | 20.0 | |||||||||
Surplus debenture interest
|
48.7 | - | 48.7 | |||||||||
Administrative services and investment management fees
|
59.4 | - | 59.4 | |||||||||
Total sources of cash expected to be available to service our debt and other obligations
|
108.1 | 170.0 | 278.1 | |||||||||
Uses of holding company cash:
|
||||||||||||
Debt service commitments of CNO:
|
||||||||||||
Estimated interest payments
|
74.8 | - | 74.8 | |||||||||
Scheduled principal payments under the:
|
||||||||||||
Senior Note
|
25.0 | - | 25.0 | |||||||||
Senior Credit Agreement
|
17.5 | - | 17.5 | |||||||||
Capital contributions to our insurance
subsidiaries
|
- | 140.0 | 140.0 | |||||||||
Corporate expense and other
|
47.3 | - | 47.3 | |||||||||
Total expected uses of cash
|
164.6 | 140.0 | 304.6 | |||||||||
Net expected increase (decrease) in cash
|
(56.5 | ) | $ | 30.0 | (26.5 | ) | ||||||
Cash balance, beginning of period (a)
|
129.9 | 129.9 | ||||||||||
Projected cash balance, end of period (a)
|
$ | 73.4 | $ | 103.4 |
(a)
|
Includes cash balances of our other non-insurance subsidiaries, which are available to CDOC or CNO.
|
Balance or
|
||||||
ratio as of
|
Margin for adverse
|
|||||
Covenant under the
|
June 30,
|
development from
|
||||
Senior Credit Agreement
|
2010
|
June 30, 2010 levels
|
||||
Aggregate risk-based capital ratio
|
Greater than or equal to 200% through December 31, 2010; greater than or equal to 225% from March 31, 2011 through December 31, 2011; and thereafter, greater than 250%.
|
318% |
Reduction to total adjusted capital (defined as combined statutory capital and surplus plus the asset valuation reserve and 50 percent of the balance of the provision of policyholder dividends) of approximately $555 million, or an increase to required risk-based capital of approximately $277 million.
|
|||
Combined statutory capital and surplus
|
Greater than $1,100 million through December 31, 2010; greater than $1,200 million from March 31, 2011 through December 31, 2011; and thereafter, $1,300 million.
|
$1,496 million
|
Reduction to combined statutory capital and surplus of approximately $396 million.
|
|||
Debt to total capitalization ratio
|
Not more than 30%.
|
21% |
Reduction to shareholders’ equity of approximately $1.4 billion or additional debt of $609 million.
|
|||
Interest coverage ratio
|
Greater than or equal to 1.50 to 1 for rolling four quarters through December 31, 2010; greater than or equal to 1.75 to 1 for rolling four quarters from March 31, 2011 through December 31, 2011; and thereafter, 2.00 to 1.
|
1.76 to 1
|
Reduction in cash flows to the holding company of approximately $19 million.
|
Gross
|
Gross
|
Estimated
|
||||||||||||||
Amortized
|
unrealized
|
unrealized
|
fair
|
|||||||||||||
cost
|
gains
|
losses
|
value
|
|||||||||||||
Investment grade (a):
|
||||||||||||||||
Corporate securities
|
$ | 13,480.8 | $ | 901.0 | $ | (141.0 | ) | $ | 14,240.8 | |||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
155.0 | 6.9 | - | 161.9 | ||||||||||||
States and political subdivisions
|
1,295.3 | 32.8 | (41.8 | ) | 1,286.3 | |||||||||||
Debt securities issued by foreign governments
|
.9 | .1 | - | 1.0 | ||||||||||||
Asset-backed securities
|
244.6 | 5.4 | (8.0 | ) | 242.0 | |||||||||||
Collateralized debt obligations
|
134.7 | 1.8 | (3.6 | ) | 132.9 | |||||||||||
Commercial mortgage-backed securities
|
1,158.5 | 45.1 | (39.6 | ) | 1,164.0 | |||||||||||
Mortgage pass-through securities
|
34.3 | 1.9 | - | 36.2 | ||||||||||||
Collateralized mortgage obligations
|
976.4 | 36.4 | (24.8 | ) | 988.0 | |||||||||||
Total investment grade actively managed fixed maturities
|
17,480.5 | 1,031.4 | (258.8 | ) | 18,253.1 | |||||||||||
Below-investment grade (a):
|
||||||||||||||||
Corporate securities
|
1,179.5 | 6.3 | (55.4 | ) | 1,130.4 | |||||||||||
States and political subdivisions
|
4.8 | - | (1.6 | ) | 3.2 | |||||||||||
Asset-backed securities
|
57.2 | .9 | (6.6 | ) | 51.5 | |||||||||||
Collateralized debt obligations
|
10.1 | - | - | 10.1 | ||||||||||||
Commercial mortgage-backed securities
|
13.3 | - | (8.3 | ) | 5.0 | |||||||||||
Collateralized mortgage obligations
|
534.9 | 3.7 | (56.2 | ) | 482.4 | |||||||||||
Total below-investment grade actively managed fixed maturities
|
1,799.8 | 10.9 | (128.1 | ) | 1,682.6 | |||||||||||
Total actively managed fixed maturities
|
$ | 19,280.3 | $ | 1,042.3 | $ | (386.9 | ) | $ | 19,935.7 | |||||||
Equity securities
|
$ | 30.7 | $ | .8 | $ | (.5 | ) | $ | 31.0 |
(a)
|
Investment ratings – Investment ratings are assigned the second lowest rating by a nationally recognized statistical rating organization (Moody’s, S&P or Fitch Ratings (“Fitch”)), or if not rated by such firms, the rating assigned by the NAIC. NAIC designations of “1” or “2” include fixed maturities generally rated investment grade (rated “Baa3” or higher by Moody’s or rated “BBB-” or higher by S&P and Fitch. NAIC designations of “3” through “6” are referred to as below-investment grade (which generally are rated “Ba1” or lower by Moody’s or rated “BB+” or lower by S&P and Fitch). References to investment grade or below-investment grade throughout our consolidated financial statements are determined as described above.
|
Percent of
|
||||||||||||||||
Gross
|
gross
|
|||||||||||||||
Percent of
|
unrealized
|
unrealized
|
||||||||||||||
Carrying value
|
fixed maturities
|
losses
|
losses
|
|||||||||||||
Utilities
|
$ | 2,056.4 | 10.3 | % | $ | 4.3 | 1.1 | % | ||||||||
Energy/pipelines
|
1,788.9 | 9.0 | 30.3 | 7.8 | ||||||||||||
Collateralized mortgage obligations
|
1,470.4 | 7.4 | 81.0 | 20.9 | ||||||||||||
Healthcare/pharmaceuticals
|
1,338.6 | 6.7 | 2.5 | .6 | ||||||||||||
States and political subdivisions
|
1,289.5 | 6.5 | 43.4 | 11.2 | ||||||||||||
Food/beverage
|
1,238.8 | 6.2 | 2.2 | .6 | ||||||||||||
Commercial mortgage-backed securities
|
1,169.0 | 5.9 | 47.9 | 12.4 | ||||||||||||
Insurance
|
1,159.7 | 5.8 | 34.7 | 9.0 | ||||||||||||
Banks
|
969.1 | 4.8 | 60.0 | 15.5 | ||||||||||||
Cable/media
|
844.1 | 4.2 | 10.1 | 2.6 | ||||||||||||
Real estate/REITs
|
785.0 | 3.9 | 5.9 | 1.5 | ||||||||||||
Capital goods
|
671.0 | 3.4 | 5.0 | 1.3 | ||||||||||||
Aerospace/defense
|
560.8 | 2.8 | .1 | - | ||||||||||||
Transportation
|
508.2 | 2.5 | .8 | .2 | ||||||||||||
Telecom
|
475.1 | 2.4 | 7.3 | 1.9 | ||||||||||||
Building materials
|
398.9 | 2.0 | 6.2 | 1.6 | ||||||||||||
Asset-backed securities
|
293.5 | 1.5 | 14.6 | 3.8 | ||||||||||||
Metals and mining
|
265.6 | 1.3 | .7 | .2 | ||||||||||||
Consumer products
|
251.8 | 1.3 | .3 | .1 | ||||||||||||
Chemicals
|
235.9 | 1.2 | 1.1 | .3 | ||||||||||||
Brokerage
|
235.3 | 1.2 | 3.8 | 1.0 | ||||||||||||
Entertainment/hotels
|
223.7 | 1.1 | 1.1 | .3 | ||||||||||||
Paper
|
198.1 | 1.0 | 8.4 | 2.2 | ||||||||||||
Other
|
1,508.3 | 7.6 | 15.2 | 3.9 | ||||||||||||
Total actively managed fixed maturities
|
$ | 19,935.7 | 100.0 | % | $ | 386.9 | 100.0 | % |
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Actively managed fixed maturity securities:
|
||||||||||||||||
Realized gains on sale
|
$ | 60.8 | $ | 73.8 | $ | 111.6 | $ | 162.0 | ||||||||
Realized losses on sale
|
(48.9 | ) | (62.8 | ) | (82.4 | ) | (67.1 | ) | ||||||||
Net impairment losses recognized in earnings
|
(14.8 | ) | (20.9 | ) | (22.8 | ) | (104.4 | ) | ||||||||
Net realized investment gains (losses) from fixed maturities
|
(2.9 | ) | (9.9 | ) | 6.4 | (9.5 | ) | |||||||||
Commercial mortgage loans
|
- | - | .1 | - | ||||||||||||
Other-than-temporary declines in fair value of mortgage loans and other invested assets
|
(13.1 | ) | (15.7 | ) | (25.4 | ) | (24.2 | ) | ||||||||
Other
|
(.7 | ) | 9.3 | (2.7 | ) | 10.5 | ||||||||||
Net realized investment losses
|
$ | (16.7 | ) | $ | (16.3 | ) | $ | (21.6 | ) | $ | (23.2 | ) |
At date of sale
|
||||||||||||
Number
|
Amortized
|
Fair
|
||||||||||
of issuers
|
cost
|
value
|
||||||||||
Less than 6 months prior to sale
|
2 | $ | 18.3 | $ | 14.2 | |||||||
Greater than or equal to 6 and less than 12 months prior to sale
|
2 | .3 | .1 | |||||||||
Greater than 12 months prior to sale
|
19 | 129.5 | 70.2 | |||||||||
23 | $ | 148.1 | $ | 84.5 |
Estimated
|
||||||||
Amortized
|
fair
|
|||||||
cost
|
value
|
|||||||
(Dollars in millions)
|
||||||||
Due in one year or less
|
$ | 7.8 | $ | 7.8 | ||||
Due after one year through five years
|
211.6 | 201.1 | ||||||
Due after five years through ten years
|
782.3 | 745.8 | ||||||
Due after ten years
|
2,559.9 | 2,367.1 | ||||||
Subtotal
|
3,561.6 | 3,321.8 | ||||||
Structured securities
|
1,291.7 | 1,144.6 | ||||||
Total
|
$ | 4,853.3 | $ | 4,466.4 |
Number
|
Cost
|
Unrealized
|
Estimated
|
|||||||||||||
of issuers
|
basis
|
loss
|
fair value
|
|||||||||||||
Less than 6 months
|
9 | $ | 47.2 | $ | (10.9 | ) | $ | 36.3 | ||||||||
Greater than 12 months
|
11 | 132.3 | (38.9 | ) | 93.4 | |||||||||||
20 | $ | 179.5 | $ | (49.8 | ) | $ | 129.7 |
Investment grade
|
Below investment grade
|
Total gross
|
||||||||||||||||||
B+ and
|
unrealized
|
|||||||||||||||||||
AAA/AA/A
|
BBB
|
BB
|
below
|
losses
|
||||||||||||||||
Collateralized mortgage obligations
|
$ | 24.4 | $ | .4 | $ | 6.6 | $ | 49.6 | $ | 81.0 | ||||||||||
Banks
|
25.1 | 24.7 | 10.2 | - | 60.0 | |||||||||||||||
Commercial mortgage-backed securities
|
20.8 | 18.8 | 4.9 | 3.4 | 47.9 | |||||||||||||||
States and political subdivisions
|
18.2 | 23.6 | 1.6 | - | 43.4 | |||||||||||||||
Insurance
|
12.1 | 19.0 | 1.3 | 2.3 | 34.7 | |||||||||||||||
Energy/pipelines
|
- | 29.2 | .9 | .1 | 30.2 | |||||||||||||||
Asset-backed securities
|
7.0 | 1.0 | 2.1 | 4.5 | 14.6 | |||||||||||||||
Cable/media
|
- | 3.6 | 3.7 | 2.8 | 10.1 | |||||||||||||||
Paper
|
- | 3.3 | 5.0 | .1 | 8.4 | |||||||||||||||
Telecom
|
.9 | 2.5 | 3.9 | .1 | 7.4 | |||||||||||||||
Building materials
|
- | 1.0 | 5.1 | .1 | 6.2 | |||||||||||||||
Real estate/REITs
|
- | 2.7 | 2.8 | .4 | 5.9 | |||||||||||||||
Capital goods
|
1.8 | .8 | 2.3 | .1 | 5.0 | |||||||||||||||
Utilities
|
.3 | 1.1 | - | 2.9 | 4.3 | |||||||||||||||
Brokerage
|
2.7 | 1.0 | - | - | 3.7 | |||||||||||||||
Collateralized debt obligations
|
2.0 | 1.6 | - | - | 3.6 | |||||||||||||||
Healthcare/pharmaceuticals
|
1.0 | .1 | 1.0 | .3 | 2.4 | |||||||||||||||
Food/beverage
|
- | 1.6 | .5 | .1 | 2.2 | |||||||||||||||
Gaming
|
- | - | .1 | 1.3 | 1.4 | |||||||||||||||
Technology
|
- | .7 | .2 | .3 | 1.2 | |||||||||||||||
Chemicals
|
- | .8 | .3 | .1 | 1.2 | |||||||||||||||
Entertainment/hotels
|
- | - | 1.1 | - | 1.1 | |||||||||||||||
Retail
|
- | .2 | .6 | .2 | 1.0 | |||||||||||||||
Transportation
|
- | .6 | .2 | - | .8 | |||||||||||||||
Metals and mining
|
- | .7 | - | - | .7 | |||||||||||||||
Textiles
|
- | - | - | .4 | .4 | |||||||||||||||
Consumer products
|
- | - | - | .3 | .3 | |||||||||||||||
Autos
|
- | - | - | .3 | .3 | |||||||||||||||
Aerospace/defense
|
- | - | .1 | - | .1 | |||||||||||||||
Other
|
.5 | 3.0 | 3.1 | .8 | 7.4 | |||||||||||||||
Total actively managed fixed maturities
|
$ | 116.8 | $ | 142.0 | $ | 57.6 | $ | 70.5 | $ | 386.9 |
Less than 12 months
|
12 months or greater
|
Total
|
||||||||||||||||||||||
Estimated fair
|
Unrealized
|
Estimated fair
|
Unrealized
|
Estimated fair
|
Unrealized
|
|||||||||||||||||||
Description of securities
|
value
|
losses
|
value
|
losses
|
value
|
losses
|
||||||||||||||||||
Corporate securities
|
$ | 1,138.7 | $ | (43.6 | ) | $ | 1,774.1 | $ | (152.8 | ) | $ | 2,912.8 | $ | (196.4 | ) | |||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
1.0 | - | - | - | 1.0 | - | ||||||||||||||||||
States and political subdivisions
|
146.0 | (3.3 | ) | 262.0 | (40.1 | ) | 408.0 | (43.4 | ) | |||||||||||||||
Asset-backed securities
|
60.7 | (1.7 | ) | 85.1 | (12.9 | ) | 145.8 | (14.6 | ) | |||||||||||||||
Collateralized debt obligations
|
76.6 | (3.6 | ) | - | - | 76.6 | (3.6 | ) | ||||||||||||||||
Commercial mortgage-backed securities
|
132.6 | (5.3 | ) | 147.2 | (42.6 | ) | 279.8 | (47.9 | ) | |||||||||||||||
Mortgage pass-through securities
|
.1 | - | 3.8 | - | 3.9 | - | ||||||||||||||||||
Collateralized mortgage obligations
|
202.2 | (3.0 | ) | 436.3 | (78.0 | ) | 638.5 | (81.0 | ) | |||||||||||||||
Total actively managed fixed maturities
|
$ | 1,757.9 | $ | (60.5 | ) | $ | 2,708.5 | $ | (326.4 | ) | $ | 4,466.4 | $ | (386.9 | ) |
Par
|
Amortized
|
Estimated
|
||||||||||
value
|
cost
|
fair value
|
||||||||||
Below 4 percent
|
$ | 179.2 | $ | 149.4 | $ | 147.6 | ||||||
4 percent – 5 percent
|
153.2 | 150.6 | 157.0 | |||||||||
5 percent – 6 percent
|
2,047.6 | 1,987.4 | 1,957.5 | |||||||||
6 percent – 7 percent
|
818.9 | 774.4 | 754.3 | |||||||||
7 percent – 8 percent
|
76.4 | 75.6 | 68.6 | |||||||||
8 percent and above
|
26.6 | 26.6 | 27.1 | |||||||||
Total structured securities
|
$ | 3,301.9 | $ | 3,164.0 | $ | 3,112.1 |
Estimated fair value
|
||||||||||||
Percent
|
||||||||||||
Amortized
|
of fixed
|
|||||||||||
Type
|
cost
|
Amount
|
maturities
|
|||||||||
Pass-throughs, sequential and equivalent securities
|
$ | 951.2 | $ | 953.3 | 4.8 | % | ||||||
Planned amortization classes, target amortization classes and accretion-directed bonds
|
580.1 | 538.6 | 2.7 | |||||||||
Commercial mortgage-backed securities
|
1,171.8 | 1,169.0 | 5.9 | |||||||||
Asset-backed securities
|
301.8 | 293.5 | 1.5 | |||||||||
Collateralized debt obligations
|
144.8 | 143.0 | .7 | |||||||||
Other
|
14.3 | 14.7 | - | |||||||||
Total structured securities
|
$ | 3,164.0 | $ | 3,112.1 | 15.6 | % |
Estimated fair
|
||||||||
Loan-to-value ratio (a)
|
Carrying value
|
value
|
||||||
Less than 60%
|
$ | 714.2 | $ | 751.9 | ||||
60% to 70%
|
755.0 | 716.3 | ||||||
70% to 80%
|
376.3 | 361.6 | ||||||
80% to 90%
|
50.7 | 47.4 | ||||||
Greater than 90%
|
51.9 | 45.9 | ||||||
Total
|
$ | 1,948.1 | $ | 1,923.1 |
(a)
|
Loan-to-value ratios are calculated as the ratio of: (i) the carrying value of the commercial mortgage loans; to (ii) the estimated fair value of the underlying commercial property.
|
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Revenues:
|
||||||||||||||||
Net investment income – policyholder and reinsurer accounts and
other special-purpose portfolios
|
$ | 5.0 | $ | 3.5 | $ | 10.4 | $ | 7.8 | ||||||||
Fee revenue and other income
|
.2 | .1 | .4 | .2 | ||||||||||||
Total revenues
|
5.2 | 3.6 | 10.8 | 8.0 | ||||||||||||
Expenses:
|
||||||||||||||||
Interest expense
|
3.9 | 3.6 | 6.9 | 7.9 | ||||||||||||
Other operating expenses
|
.2 | .1 | .4 | .2 | ||||||||||||
Total expenses
|
4.1 | 3.7 | 7.3 | 8.1 | ||||||||||||
Income (loss) before net realized investment losses
and income taxes
|
1.1 | (.1 | ) | 3.5 | (.1 | ) | ||||||||||
Net realized investment losses
|
(1.4 | ) | (3.0 | ) | (2.7 | ) | (10.8 | ) | ||||||||
Income (loss) before income taxes
|
$ | (.3 | ) | $ | (3.1 | ) | $ | .8 | $ | (10.9 | ) |
Percent of
|
||||||||||||||||
Percent
|
Gross
|
gross
|
||||||||||||||
of fixed
|
unrealized
|
unrealized
|
||||||||||||||
Carrying value
|
maturities
|
losses
|
losses
|
|||||||||||||
Cable/media
|
$ | 79.1 | 16.5 | % | $ | 3.6 | 16.3 | % | ||||||||
Healthcare/pharmaceuticals
|
64.9 | 13.6 | 1.9 | 8.9 | ||||||||||||
Chemicals
|
28.8 | 6.0 | 1.3 | 6.0 | ||||||||||||
Utilities
|
27.0 | 5.7 | 2.4 | 11.2 | ||||||||||||
Retail
|
25.9 | 5.4 | 1.0 | 4.7 | ||||||||||||
Capital goods
|
23.9 | 5.0 | .8 | 3.8 | ||||||||||||
Food/beverage
|
21.7 | 4.6 | .7 | 3.0 | ||||||||||||
Autos
|
18.7 | 3.9 | .7 | 3.2 | ||||||||||||
Gaming
|
18.5 | 3.9 | 2.0 | 9.0 | ||||||||||||
Entertainment/hotels
|
17.4 | 3.6 | .6 | 2.8 | ||||||||||||
Consumer products
|
17.3 | 3.6 | .7 | 3.0 | ||||||||||||
Energy/pipelines
|
16.9 | 3.5 | 1.7 | 7.7 | ||||||||||||
Paper
|
15.2 | 3.2 | .4 | 2.0 | ||||||||||||
Aerospace/defense
|
14.4 | 3.0 | .2 | 1.1 | ||||||||||||
Technology
|
9.3 | 1.9 | .5 | 2.2 | ||||||||||||
Other
|
79.4 | 16.6 | 3.3 | 15.1 | ||||||||||||
Total
|
$ | 478.4 | 100.0 | % | $ | 21.8 | 100.0 | % |
Estimated
|
||||||||
Amortized
|
fair
|
|||||||
cost
|
value
|
|||||||
(Dollars in millions)
|
||||||||
Due in one year or less
|
$ | .9 | $ | .9 | ||||
Due after one year through five years
|
358.2 | 337.7 | ||||||
Due after five years through ten years
|
33.5 | 32.2 | ||||||
Total
|
$ | 392.6 | $ | 370.8 |
Number
|
Cost
|
Unrealized
|
Estimated
|
|||||||||||||
of issuers
|
basis
|
loss
|
fair value
|
|||||||||||||
Less than 6 months
|
3 | $ | 7.7 | $ | (1.7 | ) | $ | 6.0 | ||||||||
Greater than 12 months
|
5 | 6.5 | (2.3 | ) | 4.2 | |||||||||||
8 | $ | 14.2 | $ | (4.0 | ) | $ | 10.2 |
Period
|
Total number of
shares (or units) (a)
|
Average price paid per share
(or unit)
|
Total number of
shares (or units) purchased as part of publicly announced
plans or programs
|
Maximum number (or approximate dollar value)
of shares (or units) that
may yet be purchased
under the plans or programs
|
||||||||||||
(dollars in millions)
|
||||||||||||||||
April 1 through April 30
|
- | $ | - | - | $ | 262.8 | ||||||||||
May 1 through May 31
|
5,961 | 6.07 | - | 262.8 | ||||||||||||
June 1 through June 30
|
- | - | - | 262.8 | ||||||||||||
Total
|
5,961 | 6.07 | - | 262.8 |
(a)
|
The Company purchased 5,961 shares of its common stock in May 2010 in connection with employee benefit compensation plans. Such purchases are not included against the maximum number of shares that may be purchased as part of our publicly announced share repurchase program.
|
10.25
|
Amended and Restated Employment Agreement dated as of May 25, 2010 between Conseco Services, LLC and Susan L. Menzel.
|
10.27
|
Amendment to Amended and Restated Employment Agreement dated as of May 1, 2010 between Conseco Services, LLC and Christopher J. Nickele.
|
10.32
|
Amended and Restated Employment Agreement dated as of May 26, 2010 between CNO Financial Group, Inc. and Edward J. Bonach.
|
10.36
|
Amended and Restated Employment Agreement dated as of May 26, 2010 between Conseco Services, LLC and Steven M. Stecher.
|
12.1
|
Computation of Ratio of Earnings to Fixed Charges.
|
31.1
|
Certification Pursuant to the Securities Exchange Act Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
31.2
|
Certification Pursuant to the Securities Exchange Act Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
32.1
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
32.2
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
101
|
The following materials from CNO Financial Group, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheet; (ii) Consolidated Statement of Operations; (iii) Consolidated Statement of Shareholders’ Equity; (iv) Consolidated Statement of Cash Flows; and (v) Notes to Consolidated Financial Statements, tagged as blocks of text.
|
By:
|
/s/ Edward J. Bonach
|
|
Edward J. Bonach
|
||
Executive Vice President and Chief Financial Officer
|
||
(authorized officer and principal financial officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Suppliers
Supplier name | Ticker |
---|---|
Johnson & Johnson | JNJ |
Pfizer Inc. | PFE |
Merck & Co., Inc. | MRK |
Abbott Laboratories | ABT |
Bristol-Myers Squibb Company | BMY |
AbbVie Inc. | ABBV |
Amgen Inc. | AMGN |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|